UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~March 31, 2021~~September 30, 2022

¨or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Clarim Acquisition Corp.

(Exact name of registrant as specified in its charter)

Delaware		001-39954		85-3812991
(State or other jurisdiction of ~~incorporation)~~incorporation or organization)		(Commission File Number)		(~~IRS~~I.R.S. Employer Identification No.)

~~245 Fifth Avenue, Suite 1500~~155 East 44^th Street, 18^th Floor

New York, NY ~~10016~~

(Address of principal executive ~~offices, including zip code)~~offices)

10017

(Zip Code)

(917) 636-7925

Registrant’s telephone number, including area ~~code:~~ ~~(917) 636-7925~~code

Not Applicable

(Former name, or former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one share of Class A Common Stock and one-third of one Redeemable Warrant	CLRMU	The Nasdaq Stock Market LLC

Class A Common Stock, par value $0.0001 per share	CLRM	The Nasdaq Stock Market LLC

Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock for $11.50 per share	CLRMW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐☒ No ☒☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

☐ Large accelerated filer	☐ Accelerated filer
☒ Non-accelerated filer	☒ Smaller reporting company
	☒ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☒ No ☐

As of ~~May 21, 2021,~~November 14, 2022, there were 28,750,000 shares of Class A common stock, par value $0.0001 per share and 7,187,500 shares of ~~the Company’s~~ Class B common stock, par value $0.0001 per share, of the registrant issued and outstanding.

CLARIM ACQUISITION CORP.

Quarterly Report on Form 10-Q

for the Quarter Ended September 30, 2022

Table of Contents

PART I. FINANCIAL INFORMATION			1

Item 1.	Financial Statements		1

	Condensed Balance Sheets as of ~~March 31, 2021 (unaudited)~~September 30, 2022 (Unaudited) and December 31, ~~2020~~2021		1

	Unaudited Condensed ~~Statement~~Statements of Operations for the ~~three months ended March 31,~~Three and Nine Months Ended September 30, 2022 and 2021		2

	Unaudited Condensed ~~Statement~~Statements of Changes in Stockholders’ ~~Equity~~Deficit for the ~~three months ended March 31,~~Three and Nine Months Ended September 30, 2022 and 2021		3

	Unaudited Condensed ~~Statement~~Statements of Cash Flows for the ~~three months ended March 31,~~Nine Months Ended September 30, 2022 and 2021		4

	Notes to Unaudited Condensed Financial Statements		5

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	17	20

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	19	23

Item 4.	Controls and Procedures	19	24

PART II. OTHER INFORMATION		20	25

Item 1.	Legal Proceedings	20	25

Item 1A.	Risk Factors	20	25

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	21	26

Item 3.	Defaults Upon Senior Securities	21	26

Item 4.	Mine Safety Disclosures	21	26

Item 5.	Other Information	21	26

Item 6.	Exhibits	22	27

SIGNATURES		23	28

GLOSSARY OF TERMS

Unless otherwise stated in this Report (as defined below), or the context otherwise requires, references to:

●

“ASC” are to the FASB (as defined below) Accounting Standards Codification;

●

“ASU” are to the FASB (as defined below) Accounting Standards Update;

●

“board of directors,” “board” or “directors” are to the board of directors of the Company (as defined below);

●

“Business Combination” are to a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses;

●

“Class A common stock” are to the shares of Class A common stock of the Company, par value $0.0001 per share;

●

“Class B common stock” are to the shares of Class B common stock of the Company, par value $0.0001 per share;

●

“common stock” are to the Class A common stock and the Class B common stock;

●

“Combination Period” are to the 24-month period, from the closing of the Initial Public Offering (as defined below) to February 2, 2023, that the Company has to consummate an initial Business Combination;

●

“Company,” “our Company,” “we” or “us” are to Clarim Acquisition Corp., a Delaware corporation;

●

“Exchange Act” are to the Securities Exchange Act of 1934, as amended;

●

“FASB” are to the Financial Accounting Standards Board;

●

“Founder Shares” are to the shares of Class B common stock initially purchased by our Sponsor (as defined below) in the Private Placement (as defined below) and the shares of Class A common stock that will be issued upon the automatic conversion of the shares of Class B common stock at the time of our Business Combination as described herein (for the avoidance of doubt, such Class A common stock will not be “Public Shares” (as defined below);

●

“GAAP” are to the accounting principles generally accepted in the United States of America;

●

“Initial Public Offering” or “IPO” are to the initial public offering that was consummated by the Company on February 2, 2021;

●

“Initial Stockholders” are to holders of our Founder Shares prior to our Initial Public Offering;

●

“Investment Company Act” are to the Investment Company Act of 1940, as amended;

●

“JOBS Act” are to the Jumpstart Our Business Startups Act of 2012;

●

“Private Placement” are to the private placement of warrants that occurred simultaneously with the closing of our Initial Public Offering;

●

“Private Placement Warrants” are to the warrants issued to our Sponsor in the Private Placement;

●

“Public Shares” are to the shares of Class A common stock sold as part of the Units (as defined below) in our Initial Public Offering (whether they were purchased in our Initial Public Offering or thereafter in the open market);

●

“Public Stockholders” are to the holders of our Public Shares, including our Initial Stockholders and management team to the extent our Initial Stockholders and/or members of our management team purchase Public Shares, provided that each Initial Stockholder’s and member of our management team’s status as a “Public Stockholder” will only exist with respect to such Public Shares;

●

“Public Warrants” refer to the redeemable warrants sold as part of the Units in our Initial Public Offering (whether they were subscribed for in our Initial Public Offering or purchased in the open market);

●

“Registration Statement” are to the Registration Statement on Form S-1 initially filed with the SEC (as defined below) on January 13, 2021, as amended, and declared effective on January 28, 2021 (File No. 333-252086);

●

“Report” are to this Quarterly Report on Form 10-Q for the quarter ended September 30, 2022;

●

“SAB” are to the SEC Staff Accounting Bulletin;

●

“Sarbanes-Oxley Act” are to the Sarbanes-Oxley Act of 2002;

●

“SEC” are to the U.S. Securities and Exchange Commission;

●

“Securities Act” are to the Securities Act of 1933, as amended;

●

“Sponsor” are to Clarim Partners, LLC, a Delaware limited liability company; James F. McCann, our Chairman and Chief Executive Officer is the managing member of our Sponsor;

●

“Sponsor IPO Loan” are to the loan of an aggregate of up to $300,000 the Sponsor agreed to lend the Company to be used for a portion of the expenses of the IPO;

●

“Trust Account” are to the U.S.-based trust account in which an amount of $287,500,000 from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Warrants was placed following the closing of the Initial Public Offering;

●

“Units” are to the units sold in our Initial Public Offering, which consist of one Public Share and one-third of one Public Warrant;

●

“warrants” are to Public Warrants and Private Placement Warrants, together;

●

“Working Capital Loans” are to funds that, in order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company;

●

“Working Capital Note I” are to the promissory note of up to $750,000 the Company entered into with the Sponsor on November 19, 2021;

●

Working Capital Note II” are to the promissory note of up to $600,000 the Company entered into with the Sponsor on March 31, 2022; and

●

“Working Capital Notes” are to Working Capital Note I and Working Capital Note II, together.

iii

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL ~~STATEMENTS~~STATEMENTS.

CLARIM ACQUISITION CORP.

CONDENSED BALANCE SHEETS

March 31,
2021 December 31,
2020
(unaudited)
Assets
Current asset - Cash $ 721,945 $ -
Prepaid expenses 733,275 -
Deferred offering costs - 106,575
Total current assets 1,455,220 106,575
Cash and securities held in Trust Account 287,518,447 -
Total Assets $ 288,973,667 $ 106,575

Liabilities and Stockholders’ Equity
Current liabilities:
Accrued offering costs and expenses $ 26,075 $ 1,430
Due to related party 3,000 -
Promissory note - related party 442 81,575
Total current liabilities 29,517 83,005
Warrant liability 10,540,000 -
Deferred underwriting discount 10,062,500 -
Total liabilities 20,632,017 83,005

Commitments and Contingencies
Class A common stock subject to possible redemption, 26,334,164 shares and 0 shares at redemption value at March 31, 2021 and December 31, 2020, respectively 263,341,640 -

Stockholders’ Equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; none issued and outstanding - -
Class A common stock, $0.0001 par value; 320,000,000 shares authorized; 2,415,836 shares and 0 shares issued and outstanding (excluding 26,334,164 shares and 0 shares subject to possible redemption) at March 31, 2020 and December 31, 2020, respectively 242 -
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 7,187,500 and 7,187,500 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively 719 719
Additional paid-in capital 1,677,831 24,281
Retained earnings (accumulated deficit) 3,321,218 (1,430 )
Total stockholders’ equity 5,000,010 23,570
Total Liabilities and Stockholders’ Equity $ 288,973,667 $ 106,575
September 30,
2022 December 31,
2021
(Unaudited)
Assets
Current asset - cash $ 154,266 $ 107,125
Prepaid expenses 150,690 392,500
Total current assets 304,956 499,625
Prepaid expenses, non-current — 31,185
Cash and marketable securities held in Trust Account 289,150,954 287,589,794
Total Assets $ 289,455,910 $ 288,120,604

Liabilities, Redeemable Common Stock and Stockholders’ Deficit
Current liabilities:
Accounts payable and accrued expenses $ 131,270 $ 332,927
Income taxes payable 77,022 —
Accrued franchise tax 150,000 200,000
Due to related party 8,000 8,000
Sponsor IPO Loan 442 442
Working Capital Notes 16,000 —
Accrued professional fees 746,987 739,841
Total current liabilities 1,129,721 1,281,210
Warrant liabilities 590,000 9,292,500
Deferred underwriting discount 10,062,500 10,062,500
Total liabilities 11,782,221 20,636,210

Commitments and Contingencies
Redeemable Common Stock
Class A common stock subject to possible redemption, 28,750,000 shares at redemption value 288,924,183 287,500,000

Stockholders’ Deficit:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; none issued and outstanding — —
Class A common stock, $0.0001 par value; 320,000,000 shares authorized; — —
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 7,187,500 shares issued and outstanding 719 719
Additional paid-in capital 250,000 —
Accumulated deficit (11,501,213 ) (20,016,325 )
Total stockholders’ deficit (11,250,494 ) (20,015,606 )
Total Liabilities, Redeemable Common Stock and Stockholders’ Deficit $ 289,455,910 $ 288,120,604
The accompanying notes are an integral part of these unaudited condensed financial statements.
1

CLARIM ACQUISITION CORP.
UNAUDITED CONDENSED ~~STATEMENT~~STATEMENTS OF OPERATIONS
For the Three
Months Ended
March 31,
2021
Operating costs $ 184,082
Loss from operations (184,082 )

Other income (expense)
Unrealized gain on change in fair value of warrants 4,018,333
Bank interest income 9
Trust interest income 18,447
Warrant issuance costs (530,059 )
Total other income 3,506,730

Net income $ 3,322,648

Basic and diluted weighted average shares outstanding, common stock subject to redemption 16,433,702
Basic and diluted net income per share $ -

Basic and diluted weighted average shares outstanding, common stock 8,962,131
Basic and diluted net income per share $ 0.37

Three Months Ended
September 30,

Nine Months Ended
September 30,

2022 2021 2022 2021

Operating costs $ 247,783 $ 1,433,999 $ 783,650 $ 2,009,443
Loss from operations (247,783 ) (1,433,999 ) (783,650 ) (2,009,443 )

Other income:
Change in fair value of warrant liabilities 1,032,500 3,149,167 8,702,500 5,413,333
Change in fair value of Working Capital Notes 28,000 -   334,000 -
Bank interest income -   16 -   43
Interest income on marketable securities held in Trust Account 1,222,941 23,672 1,763,467 58,584
Warrant issuance costs -   - -   (530,059 )
Total other income, net 2,283,441 3,172,855 10,799,967 4,941,901

Income before provision for income taxes 2,035,658 1,738,856 10,016,317 2,932,458
Provision for income taxes 72,013 -   77,022 -
Net income $ 1,963,645 $ 1,738,856 $ 9,939,295 $ 2,932,458

Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 28,750,000 28,750,000 28,750,000 25,274,725
Basic and diluted net income per share, Class A common stock subject to possible redemption $ 0.05 $ 0.05 $ 0.28 $ 0.09

Basic and diluted weighted average shares outstanding, Class B, non-redeemable common stock 7,187,500 7,187,500 7,187,500 7,074,176
Basic and diluted net income per share, Class B, non-redeemable common stock 0.05 0.05 0.28 0.09
The accompanying notes are an integral part of these unaudited condensed financial statements.
2

CLARIM ACQUISITION CORP.
UNAUDITED CONDENSED ~~STATEMENT~~STATEMENTS OF CHANGES IN STOCKHOLDERS’ ~~EQUITY~~DEFICIT
Class A Common Stock Class B Common Stock Additional
Paid-in Retained Total Stockholders'
Shares Amount Shares Amount Capital Earnings Equity
Balance as of December 31, 2020 - $ - 7,187,500 $ 719 $ 24,281 $ (1,430 ) $ 23,570
Sale of 25,000,000 Units through IPO 25,000,000 2,500 - - 249,997,500 - 250,000,000
Sale of 3,750,000 Units on through over-allotment 3,750,000 375 - - 37,499,625 - 37,500,000
Sale of 5,166,667 Private Placement Warrants - - - - 7,750,000 - 7,750,000
Underwriting fee - - - - (5,750,000 ) - (5,750,000 )
Deferred underwriting fee - - - - (10,062,500 ) - (10,062,500 )
Offering costs charged to the stockholders’ equity - - - - (413,794 ) - (413,794 )
Initial classification of warrant liability - - - - (14,558,333 ) - (14,558,333 )
Reclassification of offering costs related to warrants - - - - 530,059 - 530,059
Net income - - - - - 3,322,648 3,322,648
Change in Class A common stock subject to possible redemption (26,334,164 ) (2,633 ) - - (263,339,007 ) - (263,341,640 )

Balance as of March 31, 2021 2,415,836 $ 242 7,187,500 $ 719 $ 1,677,831 $ 3,321,218 $ 5,000,010
THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022
Class B
Common Stock Additional
Paid-in Accumulated Stockholders’
Shares Amount Capital Deficit Deficit
Balance as of December 31, 2021 7,187,500 719 — (20,016,325 ) $ (20,015,606 )

Net income — — — 6,082,039 6,082,039
Balance as of March 31, 2022 7,187,500 $ 719 $ — $ (13,934,286 ) $ (13,933,567 )

Capital contribution attributable to proceeds received in excess of fair value of Working Capital Notes — — 250,000 — 250,000

Remeasurement of Class A common stock subject to possible redemption to redemption value
— — — (322,255 ) (322,255 )

Net income — — 1,893,611 1,893,611
Balance as of June 30, 2022 7,187,500 $ 719 $ 250,000 $ (12,362,930 ) $ (12,112,211 )

Remeasurement of Class A common stock subject to possible redemption to redemption value (1,101,928 ) (1,101,928 )
Net income — — — 1,963,645 1,963,645
Balance as of September 30, 2022 7,187,500 $ 719 $ 250,000 $ (11,501,213 ) $ (11,250,494 )
THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021
Class B
Common Stock Additional
Paid-in Accumulated Stockholders’
Equity
Shares Amount Capital Deficit (Deficit)
Balance as of December 31, 2020 7,187,500 719 24,281 (1,430 ) 23,570

Excess of proceeds over fair value of Private Placement Warrants — — 2,583,333 — 2,583,333

Remeasurement of Class A common stock under ASC 480-10-S99 (as defined in Note 3) — — (2,607,614 ) (22,480,287 ) (25,087,901 )

Net income — — — 3,322,648 3,322,648
Balance as of March 31, 2021 7,187,500 $ 719 $ — $ (19,159,069 ) $ (19,158,350 )

Net loss — — — (2,129,046 ) (2,129,046 )
Balance as of June 30, 2021 7,187,500 $ 719 $ — $ (21,288,115 ) $ (21,287,396 )

Net income — — — 1,738,856 1,738,856
Balance as of September 30, 2021 7,187,500 $ 719 $ — $ (19,549,259 ) $ (19,548,540 )
The accompanying notes are an integral part of these unaudited condensed financial statements.
3

CLARIM ACQUISITION CORP.
UNAUDITED CONDENSED ~~STATEMENT~~STATEMENTS OF CASH FLOWS
For the three months ended March 31, 2021

Cash flows from Operating Activities:
Net income $ 3,322,648
Adjustments to reconcile net income to net cash used in operating activities:
Warrant issuance costs 530,059
Decrease in fair value of warrants (4,018,333 )
Interest earned on cash and marketable securities held in Trust Account (18,447 )
Changes in current assets and current liabilities:
Prepaid expenses (733,275 )
Accrued offering costs and expenses 162,587
Due to related party 3,000
Net cash used in operating activities (751,761 )

Cash Flows from Investing Activities:
Investment in Trust Account (287,500,000 )
Net cash used in investing activities (287,500,000 )

Cash flows from Financing Activities:
Proceeds from Initial Public Offering, net of underwriters’ fees 281,750,000
Proceeds from private placement warrants 7,750,000
Repayment of promissory note to related party (112,500 )
Payments of offering costs (413,794 )
Net cash provided by financing activities 288,973,706

Net change in cash 721,945
Cash, beginning of the period -
Cash, end of the period $ 721,945

Supplemental disclosure of noncash investing and financing activities:
Deferred underwriting commissions charged to additional paid in capital $ 10,062,500
Initial value of Class A common stock subject to possible redemption $ 259,479,510
Change in value of Class A common stock subject to possible redemption $ 3,862,130
Deferred offering costs paid by Sponsor loan $ 31,367
Initial classification of warrant liability at issuance $ 14,558,333

For the Nine Months ended
September 30,

2022 2021

Cash flows from operating activities:
Net income $ 9,939,295 $ 2,932,458
Adjustments to reconcile net income to net cash used in operating activities:
Warrant issuance costs — 530,059
Change in fair value of warrant liabilities (8,702,500 ) (5,413,333 )
Change in fair value of Working Capital Notes (334,000 ) —
Interest earned on cash and marketable securities held in Trust Account (1,763,467 ) (58,584 )
Changes in current assets and liabilities:
Prepaid expenses 272,995 (523,579 )
Deferred legal and professional fee 715,469
Accounts payable and accrued expenses (201,657 ) 552,580
Income taxes payable 77,022 —
Accrued franchise tax (50,000 ) —
Accrued professional fees 7,146 —
Due to related party — 8,000
Net cash used in operating activities (755,166 ) (1,256,929 )

Cash Flows from Investing Activities:
Investment held in Trust Account — (287,500,000 )
Withdrawal from Trust Account to cover taxes 202,307
Net cash provided by (used in) investing activities 202,307 (287,500,000 )

Cash flows from financing activities:
Proceeds from Working Capital Notes 600,000 —
Proceeds from Initial Public Offering, net of underwriters’ fees — 281,750,000
Proceeds from Private Placement Warrants — 7,750,000
Repayment of Sponsor IPO Loan — (112,500 )
Payments of offering costs — (413,794 )
Net cash provided by financing activities 600,000 288,973,706

Net change in cash 47,141 216,777
Cash, beginning of the period 107,125 —
Cash, end of the period $ 154,266 $ 216,777

Supplemental disclosures of noncash investing and financing activities:
Capital contribution for proceeds received in excess of fair value of Working Capital Notes $ 250,000 $ —
Remeasurement of Class A common stock subject to possible redemption to redemption value $ 1,424,183 $ 25,087,901
Deferred underwriting commissions charged to additional paid in capital $ — $ 10,062,500
Deferred offering costs paid by Sponsor loan $ — $ 31,367
Initial fair value of warrant liability $ — $ 14,558,333
The accompanying notes are an integral part of these unaudited condensed financial statements.
4

CLARIM ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
NOTE 1 - ORGANIZATION AND BUSINESS OPERATIONS
~~Note 1 — Organization and Business Operations~~
Organization and General
Clarim Acquisition Corp. ~~(the “Company”)~~ is a ~~newly organized~~ blank check company incorporated as a Delaware corporation on November 4, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (“Business Combination”). The Company has not selected any specific Business Combination target and the Company has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target with respect to the Business Combination.
~~The Company has selected December 31 as its fiscal year end.~~
As of ~~March 31, 2021,~~September 30, 2022, the Company had not commenced any operations. All activity for the period from November 4, 2020 (inception) through ~~March 31, 2021~~September 30, 2022 relates to the Company’s formation and the ~~initial public offering (“IPO”),~~IPO, which is described below, and, since the closing of the IPO, the search for a prospective ~~initial~~ Business Combination. The Company will not generate any operating revenues until after the completion of its ~~initial~~ Business Combination, at the earliest. The Company ~~will generate~~generates non-operating income in the form of interest income on cash and ~~cash equivalents from~~marketable securities held in the ~~proceeds derived from the IPO, incur~~Trust Account, incurs reasonable business expenses to affect a ~~business combination~~Business Combination and ~~will recognize~~recognizes changes in the fair value of warrant liability as other income (expense).
The Company’s sponsor is Clarim Partners, LLC, a Delaware limited liability ~~company (the “Sponsor”).~~company.
Financing
~~Financing~~
The ~~registration statement~~Registration Statement for the Company’s IPO was declared effective on January 28, ~~2021 (the “Effective Date”).~~2021. On February 2, 2021, the Company consummated the IPO of 28,750,000 ~~units,~~Units, including 3,750,000 ~~units~~Units pursuant to the exercise of the underwriters’ over-allotment option in full, ~~(the “Units” and, with respect to the shares of common stock included in the Units being offered, the “Public Shares”),~~ at $10.00 per Unit, generating gross proceeds of $287,500,000, which is discussed in ~~Note 4~~Notes 3 and ~~Note~~ 7.
Simultaneously with the closing of the IPO, the Company consummated the sale of 5,166,667 Private Placement Warrants ~~(the “Private Placement Warrants”)~~ at a price of $1.50 per Private Placement Warrant in ~~a private placement~~the Private Placement to the Sponsor, generating total gross proceeds of $7,750,000.
Transaction costs amounted to $16,226,294 consisting of $5,750,000 of underwriting discount, $10,062,500 of deferred underwriting fees, and $413,794 of other offering costs.
Trust Account
Following the closing of the IPO on February 2, 2021, $287,500,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a Trust Account, which may only be invested in U.S. “government securities”, within the meaning of Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions of Rule 2a-7 promulgated under the Investment Company Act, which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its tax obligations, the proceeds from the IPO and the sale of the Private Placement Warrants will not be released from the Trust Account until the earliest to occur of: (a) the completion of the Company’s ~~initial~~ Business Combination, (b) the redemption of any shares of the Company’s Class A common stock sold in the IPO ~~(the “public shares”)~~ properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation (i) to modify the substance or timing of the Company’s obligation to provide for the redemption of the ~~public shares~~Public Shares in connection with the initial Business Combination or to redeem 100% of the Company’s ~~public shares~~Public Shares if it does not complete its initial Business Combination within ~~24 months from~~ the ~~closing of the IPO (the “Combination Period”)~~Combination Period or (ii) with respect to any other material provisions relating to stockholders’ rights or pre-initial Business Combination activity, and (c) the redemption of the Company’s ~~public shares~~Public Shares if the Company is unable to complete the initial Business Combination within the Combination Period, subject to applicable law. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors which would have priority over the claims of the Company’s ~~public stockholders.~~Public Stockholders.

5

Initial Business Combination
The Company’s Business Combination must be with one or more target businesses that together have a fair market value (as defined in Note 3) equal to at least 80% of the net balance in the Trust Account (excluding the amount of deferred underwriting discounts held and taxes payable on the income earned on the Trust Account) at the time of the signing an agreement to enter into a Business Combination. However, the Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company ~~Act of 1940, as amended (the “Investment Company Act”).~~Act. There is no assurance that the Company will be able to successfully effect a Business Combination.
The Company will provide its ~~public stockholders~~Public Stockholders with the opportunity to redeem all or a portion of their ~~public shares~~Public Shares upon the completion of the ~~initial~~ Business Combination either (i) in connection with a stockholder meeting called to approve the ~~initial~~ Business Combination or (ii) without a stockholder vote by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed ~~initial~~ Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their shares for a pro rata share of the aggregate amount then on deposit in the Trust Account (initially approximately $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations).
The shares of common stock subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with ~~Accounting Standards Codification (“ASC”)~~FASB ASC Topic 480, “Distinguishing Liabilities from ~~Equity.”~~Equity” (“ASC 480”). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon ~~such~~ consummation of athe Business Combination and after payment of deferred underwriter’s fees and commissions; if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination.
If the Company is unable to complete its ~~initial~~ Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the ~~public shares,~~Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding ~~public shares,~~Public Shares, which redemption will completely extinguish ~~public stockholders’~~Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.
The ~~sponsor,~~Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to their ~~shares of the Company’s Class B common stock~~Founder Shares and ~~shares of Class A common stock issued upon conversion thereof (the “founder shares”) and public shares~~Public Shares in connection with the completion of the ~~initial~~ Business Combination, (ii) waive their redemption rights with respect to their ~~founder shares~~Founder Shares and ~~public shares~~Public Shares in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to provide for the redemption of the ~~public shares~~Public Shares in connection with ~~an initial~~a Business Combination or to redeem 100% of the ~~public shares~~Public Shares if the Company does not complete the ~~initial~~ Business Combination within the Combination Period or (B) with respect to any other material provisions relating to ~~stockholder’s~~stockholders’ rights or pre-initial Business Combination activity, (iii) waive their rights to liquidating distributions from the Trust Account with respect to their ~~founder shares~~Founder Shares if the Company fails to complete the ~~initial~~ Business Combination within the Combination Period, and (iv) vote any ~~founder shares~~Founder Shares held by them and any ~~public shares~~Public Shares purchased during or after the ~~Proposed~~Initial Public Offering (including in open market and privately-negotiated transactions) in favor of the Company’s ~~initial~~ Business Combination.
6
The Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable), nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Company’s Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that its Sponsor would be able to satisfy those obligations.

Liquidity, ~~and~~ Capital Resources and Going Concern
As of ~~March 31, 2021,~~September 30, 2022, the Company had ~~approximately $0.7 million~~$154,266 in its operating bank account, and a working capital deficit of ~~approximately $1.4 million.~~$824,765.
Prior to the completion of the ~~Initial Public Offering,~~IPO, the Company’s liquidity needs had been satisfied through a payment from the Sponsor of $25,000 (see Note 6)5) for the Founder Shares to cover certain offering costs, and the loan ~~under an unsecured promissory note~~ from the Sponsor of $112,942 (see Note 6)5). The Company ~~fully paid~~repaid $112,500 of the ~~note~~loan to the Sponsor on February 11, 2021. Subsequent to the consummation of the ~~Initial Public Offering~~IPO and Private Placement, the Company’s liquidity needs have been satisfied through the proceeds from the consummation of the Private Placement not held in the Trust ~~Account.~~Account and Working Capital Notes (see Note 5).
In addition, in order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans ~~as defined below~~ (see Note 6)5). ~~To date,~~
On November 19, 2021 and March 31, 2022, respectively, the Company issued the Working Capital Notes to the Sponsor, pursuant to which the Company may draw down capital to fund its working capital needs or in connection with the Business Combination, up to a total principal amount of $1,350,000. The Sponsor has also informally agreed to commit additional funding, as and if necessary, of up to $500,000 upon similar terms and conditions as the Working Capital Notes. At September 30, 2022, an aggregate of $600,000 has been drawn against Working Capital Note I. At September 30, 2022, there ~~were~~was no ~~amounts~~balance outstanding under ~~any~~ Working Capital ~~Loans.~~Note II.
~~Based on~~Over the ~~foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs~~Combination Period, through the earlier of the consummation of a Business Combination or ~~one year from this filing. Over this time period,~~February 2, 2023, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective ~~initial~~ Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.
~~Note 2 —~~ ~~Restatement of Previously Issued Financial Statements~~
~~On April 12, 2021,~~The Company cannot guarantee that it will have sufficient resources to execute its business plan. Accordingly, the ~~Staff~~Company may need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms. As of the ~~Securities and Exchange Commission together issued~~date of this Report, the Company is within 12 months of its mandatory liquidation date of February 2, 2023. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASU Topic 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a ~~statement regarding~~Going Concern,” management is uncertain that the accounting and reporting considerations for warrants issued by special purpose acquisition companies entitled "Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies ("SPACs")" (the "SEC Statement"). Specifically, the SEC Statement focused on certain settlement terms and provisions relatedCompany will be able to ~~certain tender offers following~~consummate a Business Combination ~~which terms are similar~~by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that these conditions raise substantial doubt about the Company’s ability to ~~those contained in~~continue as a going concern.
No adjustments have been made to the ~~warrant agreement, dated as~~carrying amounts of ~~January 28, 2021, between~~assets or liabilities should the Company ~~and Continental Stock Transfer & Trust Company,~~be unable to continue as a New York corporation, as warrant agent (the "Warrant Agreement"). As a result of the SEC Statement, the Company reevaluated the accounting treatment of (i) the 9,583,333 Public Warrants and (ii) the 5,166,667 Private Placement Warrants (See Note 4 and Note 5). The Company previously accounted for all Warrants as components of equity.
In further consideration of the guidance in Accounting Standards Codification ("ASC") 815-40, Derivatives and Hedging; Contracts in Entity's Own Equity, the Company concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815, the Warrants should be recorded as derivative liabilities on the Balance Sheet and measured at fair value at inception (on the date of the IPO) and at each reporting date in accordance with ASC 820, Fair Value Measurement, with changes in fair value recognized in the statement of operations in the period of change.
going concern.
7

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES
After discussion with the Company's independent registered public accounting firm, the Company's management and the audit committee of the Company's Board of Directors concluded that it is appropriate to restate the Company's previously issued audited balance sheet as of February 2, 2021 as previously reported on its Form 8-K. The restated classification and reported values of the Warrants, and the allocation of offering costs, as accounted for under ASC 815-40 are included in the financial statements herein.
~~The following tables summarize the effect of the restatement on each balance sheet line item as of the date:~~
As Previously Reported Adjustment As Restated
Balance Sheet at February 2, 2021
Warrant Liability $ - $ 14,558,333 $ 14,558,333
Class A common stock subject to possible redemption 274,037,840 (14,558,330 ) 259,479,510
Class A common stock 135 145 280
Additional paid-in capital 5,010,012 529,911 5,539,923
Accumulated deficit $ (10,861 ) $ (530,059 ) $ (540,920 )
~~Note 3 — Significant Accounting Policies~~
Basis of Presentation
The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with ~~accounting principles generally accepted in the United States of America (“GAAP”)~~GAAP for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the accompanying unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair ~~statement~~presentation of the ~~balances and results~~financial statements for the periods presented. Operating results for the period for the three and nine months ended ~~March 31, 2021~~September 30, 2022 are not necessarily indicative of the results that may be expected through December 31, ~~2021.~~2022.
The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form ~~8-K and~~10-K for the ~~final prospectus~~year ended December 31, 2021, as filed ~~by the Company~~ with the SEC on ~~February 8, 2021 and February 1, 2021, respectively.~~April 14, 2022.
Emerging Growth Company Status
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, ~~of 1933, as amended, (the “Securities Act”),~~ as modified by the ~~Jumpstart our Business Startups~~JOBS Act, ~~of 2012, (the “JOBS Act”),~~ and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company ~~which~~that is neither an emerging growth company nor an emerging growth company ~~which~~that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
8
Use of Estimates
The preparation of ~~these~~the accompanying unaudited condensed financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the accompanying unaudited condensed financial statements. ~~Actual~~Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of ~~March 31, 2021~~September 30, 2022 and December 31, ~~2020.~~2021.
Cash and Securities Held in Trust Account
Investment held in Trust Account consist of United States Treasury securities. The Company classifies its United States Treasury securities as held-to-maturity in accordance with FASB ASC Topic 320, “Investments - Debt and Equity ~~Securities.”~~Securities” (“ASC 320”). Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost and adjusted for the amortization or accretion of premiums or discounts.
A decline in the market value of held-to-maturity securities below cost that is deemed to be other than temporary, results in an impairment that reduces the carrying costs to such securities’ fair value. The impairment is charged to earnings and a new cost basis for the security is established. To determine whether an impairment is other than temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery and considers whether evidence indicating the cost of the investment is recoverable outweighs evidence to the contrary. Evidence considered in this assessment includes the reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent to year-end, forecasted performance of the investee, and the general market condition in the geographic area or industry the investee operates in.
Premiums and discounts are amortized or accreted over the life of the related held-to-maturity security as an adjustment to yield using the effective-interest method. Such amortization and accretion isare included in the “Trust interest income” line item in the statements of operations. Trust interest income is recognized when earned.

Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurements and Disclosures” (“ASC 820”), approximates the carrying amounts represented in the condensed balance sheets, primarily due to its short-term nature.
Fair Value Measurements
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC ~~Topic~~ 820, ~~“Fair Value Measurement,”~~ approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. ~~Fair value~~“Fair value” is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
9
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
The fair value of the Company’s certain assets and liabilities, which qualify as financial instruments under ASC 820, ~~“Fair Value Measurements and Disclosures,”~~ approximates the carrying amounts represented in the balance sheet. The fair values of cash and cash equivalents, prepaid expenses, accounts payable and accrued expenses are estimated to approximate the carrying values as of ~~March~~September 30, 2022 and December 31, 2021 due to the short maturities of such instruments.
The Company’s warrant liability for the ~~private placement warrants~~Private Placement Warrants is based on a valuation model utilizing management judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets. Significant deviations from these estimates and inputs could result in a material change in fair value. The fair value of the warrant liability is classified as ~~level~~Level 3. See Note 76 for additional information on assets and liabilities measured at fair value.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal ~~Depository~~Deposit Insurance ~~Coverage~~Corporation coverage limit of $250,000. ~~At March 31, 2021~~As of September 30, 2022 and December 31, ~~2020,~~2021, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Common Stock Subject to Possible Redemption
The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ~~Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”~~ASC 480. Common stock subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ ~~equity.~~deficit. The Company’s common stock feature certain redemption rights that isare considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ ~~equity~~deficit section of the Company’s balance ~~sheet.~~sheets.
The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit.

Net Income Per Share of Common ~~Share~~Stock
~~Net~~The Company has two classes of common stock, which are referred to as “Class A common stock” and “Class B common stock.” Earnings and losses are shared pro rata between the two classes of shares. The 14,750,000 potential common stock for outstanding warrants to purchase the Company’s stock were excluded from diluted earnings per share for the three and nine months ended September 30, 2022 because the warrants are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net income per common ~~share~~stock is ~~computed by dividing~~the same as basic net income ~~by the weighted average number of~~per common stock ~~outstanding~~ for ~~each of~~ the periods. The ~~calculation of diluted income per common share does not consider the effect~~table below presents a reconciliation of the ~~warrants issued in connection with the (i) IPO, (ii) exercise of overallotment~~numerator and ~~(iii) Private Placement since the exercise of the warrants are contingent upon the occurrence of future events~~denominator used to compute basic and ~~the inclusion of such warrants would be anti-dilutive. The warrants are exercisable to purchase 14,750,000 shares of common stock in the aggregate.~~
~~The Company’s statement of operations includes a presentation of~~diluted net income per share for each class of common stock subject to possible redemption in a manner similar to the two-class method of loss per common share. Net income per common share, basic and diluted, for redeemable common stock is calculated by dividing the interest income earned on the Trust Account, by the weighted average number of redeemable common stock outstanding since original issuance. Net income per common share, basic and diluted, for non-redeemable common stock is calculated by dividing the net income, adjusted for income attributable to redeemable common stock, by the weighted average number of non-redeemable common stock outstanding for the periods. Non-redeemable common stock includes the founder shares as these common stock do not have any redemption features and do not participate in the income earned on the Trust Account.stock:

For the Three Months Ended
March 31, 2021

Common stock subject to possible redemption
Numerator: net income allocable to common stock subject to possible redemption
Interest income on marketable securities held in trust $ 16,897
Less: interest available to be withdrawn for payment of taxes (16,897 )
Net income allocable to common stock subject to possible redemption $ -
Denominator: Weighted average redeemable common stock 
Redeemable common stock, basic and diluted 16,433,702
Basic and diluted net income per share, redeemable common stock $ -

Non-redeemable common stock
Numerator: net income minus redeemable net earnings
Net income $ 3,322,648
Redeemable net earnings -
Non-redeemable net income $ 3,322,648
Denominator: Weighted average non-redeemable basic and diluted weighted average shares outstanding, common stock 8,962,131
Basic and diluted net income per share, common stock $ 0.37
10
For the three months ended
September 30, For the nine months ended
September 30
2022 2021 2022 2021
Class A Class B Class A Class B Class A Class B Class A Class B
Basic and diluted net income per share:
Numerator:
Allocation of net income $ 1,570,916 392,729 $ 1,391,085 347,771 $ 7,951,436 1,987,859 $ 2,291,177 641,281
Denominator:
Weighted-average shares outstanding 28,750,000 7,187,500 28,750,000 7,187,500 28,750,000 7,187,500 25,274,725 7,074,176
Basic and diluted net income per share $ 0.05 $ 0.05 $ 0.05 $ 0.05 $ 0.28 $ 0.28 $ 0.09 $ 0.09
Offering Costs ~~associated~~Associated with the Initial Public Offering
The Company complies with the requirements of ~~the~~ FASB ASC Topic 340-10-S99-1 and SAB Topic 5A, “Expenses of Offering” (“ASC 340-10-S99-1 and ~~SEC Staff Accounting Bulletin (“SAB”~~SAB 5A”) ~~Topic 5A - “Expenses of Offering”~~. Offering costs consist principally of professional and registration fees incurred through the balance sheet date. Offering costs are allocated to the separable financial instruments issued in the IPO based on a relative fair value basis compared to total proceeds received. Offering costs associated with warrant liabilities is expensed, and offering costs associated with the Class A common stock ~~are~~were charged to temporary equity upon the ~~stockholders’ equity.~~completion of the IPO.
Derivative Financial Instruments
The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). Derivative instruments are recorded at fair value on the grant date and re-valued at each reporting date, with changes in ~~the~~ fair value reported in the statements of operations. Derivative assets and liabilities are classified on the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company has determined the warrants are a derivative instrument.
FASB ASC Topic 470-20, ~~Debt~~“Debt with Conversion and Other ~~Options~~Options” addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate IPO proceeds from the Units between Class A common stock and warrants, using the residual method by allocating IPO proceeds first to fair value of the warrants and then the Class A common stock.
Working Capital Notes
The Company accounts for its Working Capital Notes under FASB ASC Topic 815 “Derivatives and Hedging” (“ASC 815”). Pursuant to ASC 815-15-25 the election can be at the inception of a financial instrument to account for the instrument under the fair value option under FASB ASC Topic 825. “Financial Instruments” (“ASC 825”). The Company has made such election for the Working Capital Notes. Using the fair value option, the Working Capital Notes are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the Working Capital Notes are recognized as a non-cash gain or loss in the condensed statements of operations.
Warrants
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all of the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. The Company accounts for the 9,583,333 Public Warrants (Note 3) and 5,166,667 Private Placement Warrants (Note 4) as liability-classified instruments, which are fair valued at each reporting date.

Income Taxes
The Company accounts for income taxes under FASB ASC Topic 740, ~~Income Taxes~~“Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the ~~unaudited condensed~~ financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of ~~March 31, 2021~~September 30, 2022 and December 31, ~~2020.~~2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
Our effective tax rate from continuing operations was 3.54% and 0.77% for the quarter and nine months ended September 30, 2022, respectively, and 0.00% and 0.00% for the quarter and nine months ended September 30, 2021, respectively.
~~The~~
For the nine months ended September 30, 2022 the Company has ~~identified~~prepared it's provision on the ~~United States as its only “major” tax jurisdiction.~~
~~The~~basis that the Company is ~~subject~~seeking and will likely be receiving approval to ~~income~~liquidate prior to December 31, 2022. Based on this assumption, the Company believes it’s effective tax ~~examinations by major taxing authorities since inception. These examinations may include questioning~~rate will be approximately 0.9% for the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.year ending December 31, 2022.
Risks and Uncertainties
~~On January 30, 2020,~~Management continues to evaluate the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus (the ”COVID-19 outbreak”). In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the COVID-19 ~~outbreak continues to evolve. The impact of~~pandemic and has concluded that while it is reasonably possible that the ~~COVID-19 outbreak~~virus could have a negative effect on the Company’s financial position, ~~will depend on future developments, including~~results of its operations, cash flows and/or search for a target company, the ~~duration and spread~~specific impact is not readily determinable as of the ~~outbreak and related advisories and restrictions. These developments and the impact~~date of the ~~COVID-19 outbreak on the~~ financial ~~markets and the overall economy are highly uncertain and cannot be predicted. If the~~statements. The financial markets and/or the overall economy are impacted for an extended period, the Company’s financial position may be materially adversely affected. Additionally, the Company’s ability to complete an initial Business Combination may be materially adversely affected due to significant governmental measures being implemented to contain the COVID-19 outbreak or treat its impact, including travel restrictions, the shutdown of businesses and quarantines, among others, which may limit the Company’s ability to have meetings with potential investors or affect the ability of a potential target company’s personnel, vendors and service providers to negotiate and consummate an initial Business Combination in a timely manner. The Company’s ability to consummate an initial Business Combination may also be dependent on the ability to raise additional equity and debt financing, which may be impacted by the COVID-19 outbreak and the resulting market downturn. The unaudited condensed financial statement doesstatements do not include any adjustments that might result from the outcome of this uncertainty.
The credit and financial markets have experienced extreme volatility and disruptions due to the current conflict between Ukraine and Russia. The conflict is expected to have further global economic consequences, including but not limited to the possibility of severely diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in inflation rates and uncertainty about economic and political stability. In addition, the United States and other countries have imposed sanctions on Russia, which increases the risk that Russia, as a retaliatory action, may launch cyberattacks against the United States, its government, infrastructure and businesses. Any of the foregoing consequences, including those the Company cannot yet predict, may cause the Company’s business, financial condition, results of operations and the price of the Company’s common stock to be adversely affected.
Inflation Reduction Act of 2022
On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.
Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.
Recent Accounting Pronouncements
In August 2020, the FASB issued ASU 2020-06, “Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40)” (“ASU 2020-06”), to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2024 for the Company and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.
Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial ~~statement.~~
statements.
11

NOTE 3 - INITIAL PUBLIC OFFERING
~~Note 4 — Initial Public Offering~~
Pursuant to the IPO on February 2, 2021, the Company sold 28,750,000 Units, including 3,750,000 Units pursuant to the exercise of the underwriters’ over-allotment option in full, at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one-third of one redeemable warrant. Each whole warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment. Each ~~warrant~~Public Warrant will become exercisable on the later of (i) 30 days after the completion of the ~~initial~~ Business Combination or ~~12 months from the closing of the IPO~~(ii) February 2, 2022 and will expire five years after the completion of the ~~initial~~ Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.
Following the closing of the IPO on February 2, 2021, $287,500,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in athe Trust Account, which may only be invested in U.S. “government securities”, within the meaning of Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions of Rule 2a-7 promulgated under the Investment Company Act, which invest only in direct U.S. government treasury obligations.
All of the 28,750,000 shares of Class A common stock sold as part of the Units in the IPO, including Units sold upon the full exercise of over-allotment by the underwriters, contain a redemption feature that allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s certificate of incorporation. In accordance with SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480 Section 480-10-S99, redemption provisions not solely within the control of the Company require common stock subject to redemption to be classified outside of permanent equity.
The Class A common stock is subject to SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company recognizes changes in redemption value immediately as they occur. Immediately upon the closing of the IPO, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable common stock resulted in charges against additional paid-in capital and accumulated deficit.
As of September 30, 2022 and December 31, 2021, the common stock reflected on the balance sheets are reconciled in the following table:
Gross proceeds from IPO $ 287,500,000
Less:
Proceeds allocated to Public Warrants (9,391,667 )
Issuance costs allocated to Class A common stock (15,696,234 )
Plus:
Remeasurement of Class A common stock to redemption value 25,087,901
Class A common stock subject to possible redemption as of December 31, 2021 287,500,000
Plus:
Remeasurement of Class A common stock to redemption value —
Class A common stock subject to possible redemption as of March 31, 2022 287,500,000
Plus:
Remeasurement of Class A common stock to redemption value 322,255
Class A common stock subject to possible redemption as of June 30, 2022 $ 287,822,255
Plus:
Remeasurement of Class A common stock to redemption value 1,101,928
Class A common stock subject to possible redemption as of September 30, 2022 $ 288,924,183
Public Warrants
Each whole ~~warrant~~Public Warrant entitles the holder to purchase one share of the Company’s Class A common stock at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the ~~initial~~ Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Company’s Sponsor or its affiliates, without taking into account any ~~founder shares~~Founder Shares held by the Sponsor or its affiliates, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the ~~initial~~ Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the ~~initial~~ Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described adjacent to “Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described adjacent to the caption “Redemption of warrants when the price per share of Class A common Stock equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.

The ~~warrants~~Public Warrants will become exercisable on the later of ~~12 months from the closing of the IPO~~(i) February 2, 2022 or (ii) 30 days after the completion of its ~~initial~~ Business Combination, and will expire five years after the completion of the Company’s ~~initial~~ Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.
The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A common stock underlying the warrants is then effective and a current prospectus relating thereto is current. No warrant will be exercisable and the Company will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In no event will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the share of Class A common stock underlying such unit.
Redemption of Warrants When the Price per Class A Common Stock Equals or Exceeds $18.00
Once the warrants become exercisable, the Company may redeem the outstanding warrants:
● in whole and not in part;
● at a price of $0.01 per warrant;
● upon a minimum of 30 days’ prior written notice of ~~redemption (the “30-day redemption period”);~~redemption; and
● if, and only if, the reported closing price of the Class A common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
12
Redemption of Warrants When the Price per Class A Common Stock Equals or Exceeds $10.00
Once the warrants become exercisable, the Company may redeem the outstanding warrants:
● in whole and not in part;
● at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined based on the redemption date and the ~~“fair~~fair market ~~value” (as defined below)~~value of the Class A common ~~stock (as defined below);~~stock;
● if, and only if, the closing price of Class A common stock equals or exceeds $10.00 per public share for any 20 trading days within the 30-trading day period ending three trading days before the Company sends notice of redemption to the warrant holders; and
● if the closing price of the Class A common stock for any 20 trading days within a 30-trading day period ending on the third trading days before the Company sends notice of redemption to the warrant holders is less than $18.00 per share, the Private Placement Warrants must also concurrently be called for redemption on the same terms as the outstanding Public Warrants, as described above.
If the Company calls the warrants for redemption as described above, the management will have the option to require all holders that wish to exercise warrants to do so on a cashless basis. In determining whether to require all holders to exercise their warrants on a cashless basis, the management will consider, among other factors, the Company’s cash position, the number of warrants that are outstanding and the dilutive effect on its stockholders of issuing the maximum number of shares of Class A common stock issuable upon the exercise of the warrants. In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of Class A common stock equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of shares of Class A common stock underlying the warrants multiplied by the excess of the “fair market value” ~~(defined below)~~ over the exercise price of the warrant by (y) the fair market value and (B) 0.361 per whole warrant. The “fair market value” shall mean the average reported closing price of the Class A common stock for the ten trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.

~~Note 5 — Private Placement~~
NOTE 4 - PRIVATE PLACEMENT
Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 5,166,667 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, for an aggregate purchase price of $7,750,000, in ~~a private placement (the “Private Placement”).~~the Private Placement.
Each Private Placement Warrant entitles the holder to purchase one share of the Class A common stock at a price of $11.50 per share. The Private Placement Warrants will be non-redeemable in certain circumstances so long as they are held by the Sponsor or its permitted transferees. The Private Placement Warrants may also be exercised by the Sponsor and its permitted transferees for cash or on a cashless basis. Otherwise, the Private Placement Warrants have terms and provisions that are identical to those of the warrants being sold as part of the Units in the IPO, including as to exercise price, exercisability and exercise period.
The Company’s Sponsor has agreed to (i) waive its redemption rights with respect to the ~~founder shares~~Founder Shares and ~~public shares~~Public Shares in connection with the completion of the Company’s ~~initial~~ Business Combination, (ii) waive its redemption rights with respect to the ~~founder shares~~Founder Shares and ~~public shares~~Public Shares in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to provide for the redemption of the Company’s ~~public shares~~Public Shares in connection with ~~an initial~~a Business Combination or to redeem 100% of the Company’s ~~public shares~~Public Shares if the Company does not complete its ~~initial~~ Business Combination within the Combination Period or (B) with respect to any other material provisions relating to stockholders’ rights or pre-initial Business Combination activity, (iii) waive its rights to liquidating distributions from the Trust Account with respect to the ~~founder shares~~Founder Shares if the Company fails to complete its ~~initial~~ Business Combination within the Combination Period, although the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any ~~public shares~~Public Shares it holds if the Company fails to complete the ~~initial~~ Business Combination within the Combination Period, and (iv) vote any ~~founder shares~~Founder Shares held by the Sponsor and any ~~public shares~~Public Shares purchased during or after the IPO (including in open market and privately-negotiated transactions) in favor of the Company’s ~~initial~~ Business Combination.
NOTE 5 - RELATED PARTY TRANSACTIONS
13
~~Note 6 — Related Party Transactions~~
Founder Shares
In November 2020, the Company’s ~~initial stockholders~~Initial Stockholders purchased an aggregate of 7,187,500 ~~founder shares~~Founder Shares for a capital contribution of $25,000. The ~~founder shares include~~Founder Shares included an aggregate of up to 937,500 shares subject to forfeiture if the over-allotment option iswas not exercised by the underwriters in full. Because of the underwriters’ ~~fully~~full exercise of the over-allotment option on February 2, 2021, 937,500 shares are no longer subject to forfeiture.
With certain limited exceptions, the ~~founder shares~~Founder Shares are not transferable, assignable or salable (except to the Company’s officers and directors and other persons or entities affiliated with the Sponsor, each of whom will be subject to the same transfer restrictions) until the earlier of (A) one year after the completion of the Company’s ~~initial~~ Business Combination or (B) subsequent to the Company’s ~~initial~~ Business Combination, (x) if the reported closing price of Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s ~~initial~~ Business Combination or (y) the date, following the completion of the Company’s ~~initial~~ Business Combination, on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property.

Due to Related Party
At September 30, 2022 and December 31, 2021, the due to related party (balance of $8,000) represents unreimbursed travel expenses payable to management.
Sponsor IPO Loan
The ~~balance of $3,000 represents the travel reimbursement to the management.~~
~~Promissory Note — Related Party~~
~~The Company’s~~ Sponsor ~~has~~ agreed to loan or fund offering costs on behalf of the Company an aggregate of up to $300,000 to be used for a portion of the expenses of the IPO. The ~~loan is~~Sponsor IPO Loan was non-interest bearing, unsecured and due at the earlier of ~~June 30,~~December 31, 2021 or the closing of the IPO. The Sponsor paid an aggregate of $112,942 under the Sponsor IPO Loan and the Company repaid $112,500 of the Sponsor IPO Loan to the Sponsor on February 11, 2021. As of ~~March~~September 30, 2022 and December 31, 2021, the Company had an outstanding balance of $442 under ~~the promissory note.~~this Sponsor IPO Loan.
Working Capital Notes
~~Related Party Loans~~
In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company ~~funds as may be required (“~~Working Capital ~~Loans”).~~Loans. If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into warrants at a price of $1.50 per warrant at the option of the ~~lender.~~lender (the “Conversion Warrants”). The ~~warrants~~Conversion Warrants would be identical to the Private Placement Warrants, including as to exercise price, exercisability and exercise period.
On November 19, 2021, the Company entered into Working Capital Note I, a promissory note of up to $750,000 with the Sponsor. Under its terms and conditions, the Company may request up to five (5) drawdowns of up to $150,000 in each instance (maximum of $750,000 in aggregate) for costs reasonably related to the Company’s ongoing working capital needs and/or in order to consummate a Business Combination with one or more businesses, if applicable. Working Capital Note I bears no interest and is not secured by the Company’s assets. Its principal balance is due and payable by the Company on the earlier of: (i) February 2, 2023 or (ii) the date on which Company consummates the Business Combination (such date, the “Maturity Date”). The principal under Working Capital Note I may be drawn down by the Company from time to time prior to the Maturity Date (each, a “Drawdown Request”). Each Drawdown Request must not be an amount less than $10,000, unless otherwise agreed upon by the parties. Each Drawdown Request by the Company shall be funded by Sponsor within five (5) business days. For the nine months ended September 30, 2022, the Company drew down an aggregate of $600,000 available under the Working Capital Note I, which was outstanding as of September 30, 2022.
At September 30, 2022, the outstanding balance of $600,000 under Working Capital Note I was convertible into 400,000 Conversion Warrants. At September 30, 2022, the fair value of the Private Placement Warrants was $0.04, which resulted in an aggregate fair value of $16,000 for Working Capital Note I. The change in fair value of $28,000 and $334,000 for the three and nine months then ended September 30, 2022, respectively, is reflected on the condensed statement of operations (see Note 6).

On March 31, 2022, the Company issued Working Capital Note II, an additional unsecured promissory note for an aggregate of up to $600,000. The proceeds of Working Capital Note II will be used for costs in connection with its initial Business Combination or as general working capital. Working Capital Note II is non-interest bearing and payable (subject to the waiver against trust provisions) on the earlier of (i) the date on which the initial Business Combination is consummated and (ii) the date of the Company’s liquidation. At September 30, 2022, there was no balance outstanding under Working Capital Note II.
Upon the consummation of the Initial Business Combination, the outstanding amount under the Working Capital Notes shall automatically convert into that number of Conversion Warrants of the Company or its successor entity, equal to: (x) the outstanding amount of the promissory note being converted, divided by (y) $1.50, rounded up to the nearest whole number of Conversion Warrants. The Conversion Warrants will be entitled to registration rights, as described in the Company’s registration rights agreement with certain other parties thereto on January 28, 2021. As of ~~March 31, 2021~~September 30, 2022 and December 31, ~~2020,~~2021, the Company had no$600,000 and nil outstanding under the Working Capital ~~Loans.~~Notes.
The issuances of the Working Capital Notes were made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
Administrative Service Fee
The Company has agreed to pay an affiliate of its Sponsor, commencing on January 28, 2021, a total of $10,000 per month for office space, utilities and secretarial and administrative support. Upon completion of the Company’s Business Combination or its liquidation, the Company will cease paying these monthly fees. For the three and nine months ended September 30, 2022, the Company incurred and paid $30,000 and $90,000 for administrative service fees, respectively. For the three and nine months ended September 30, 2021, the Company incurred and paid $30,000 and $90,000 for administrative service fees, respectively.
NOTE 6 - RECURRING FAIR VALUE MEASUREMENTS
14
~~Note 7 — Recurring Fair Value Measurements~~
Cash and Securities Held in Trust Account
As of ~~March~~September 30, 2022 and December 31, 2021, investment in the Company’s Trust Account consisted of ~~$522~~$2,627 and $656, respectively, in U.S. Money Market funds and ~~$287,517,925~~$289,148,327 and $287,589,138, respectively, in U.S. Treasury Securities. The Company classifies its ~~United States~~U. S. Treasury ~~securities~~Securities as held-to-maturity in accordance with ~~FASB~~ ASC ~~320 “Investments — Debt and Equity Securities”.~~320. Held-to-maturity ~~treasury securities~~Treasury Securities are recorded at amortized cost and adjusted for the amortization or accretion of premiums or discounts. The Company considers all investments with original maturities of more than three months but less than one year to be short-term investments. The carrying value approximates the fair value due to its short-term maturity. The carrying value, excluding gross unrealized holding loss and fair value of held to maturity securities on ~~March~~September 30, 2022 and December 31, 2021 are as follows:
Carrying
Value/
Amortized
Cost Gross
Unrealized
Gains Gross
Unrealized
Losses Fair Value
as of
September 30,
2022
U.S. Money Market $ 2,627 $ — $ — $ 2,627
U.S. Treasury Securities 289,148,327 — (37,179 ) 289,185,246
$ 289,150,954 $ — $ (37,179 ) $ 289,187,918
Carrying
Value/
Amortized
Cost Gross
Unrealized
Gains Gross
Unrealized
Losses Fair Value
as of
December 31,
2021
U.S. Money Market $ 656 $ — $        — $ 656
U.S. Treasury Securities 287,589,138 2,234 — 287,591,372
$ 287,589,794 $ 2,234 $ — $ 287,592,028

Carrying
Value/Amortized
Cost Gross
Unrealized
Gains Gross
Unrealized
Losses Fair Value
as of
March 31, 2021
U.S. Money Market $ 522 $ - $ - $ 522
U.S. Treasury Securities 287,517,925 6,324 - 287,524,249
$ 287,518,447 $ 6,324 $ - $ 287,524,771
Warrant Liability
~~At March~~As of September 30, 2022 and December 31, 2021, the Company’s warrants liability was valued at ~~$10,540,000.~~$590,000 and $9,292,500, respectively. Under the guidance in ASC 815-40, the warrants do not meet the criteria for equity treatment. As such, the warrants must be recorded on the balance ~~sheet~~sheets at fair value. This valuation is subject to re-measurement at each balance sheet date. With each re-measurement, the warrant valuation will be adjusted to fair value, with the change in fair value recognized in the Company’s ~~statement~~statements of operations.
Initial Measurement
The estimated fair value of the warrant liability on February 2, 2021 was determined using Level 3 inputs. Inherent in a Monte-Carlo simulation model are assumptions related to expected stock-price volatility (pre-merger and post-merger), expected term, dividend yield and risk-free interest rate. The Company estimates the volatility of its common stock based on management’s understanding of the volatility associated with instruments of other similar entities. The risk-free interest rate is based on the U.S. Treasury Constant Maturity similar to the expected remaining life of the warrants. The expected life of the warrants is simulated based on management assumptions regarding the timing and likelihood of completing a Business Combination. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero. The assumptions used in calculating the estimated fair values represent the Company’s best estimate. However, inherent uncertainties are involved. If factors or assumptions change, the estimated fair values could be materially different.
The key inputs into the Monte Carlo simulation model for the warrant liability were as follows as of February 2, 2021:
Input February 2,
2021
Expected term (years) 5.25
Expected volatility 18.40 %
Risk-free interest rate 0.67 %
Stock price $ 9.68
Dividend yield 0.00 %
Exercise price $ 11.50
Subsequent Measurement
The fair value of the Public Warrants as of September 30, 2022 is classified as Level 1 due to the use of an observable market quote in an active market. As of September 30, 2022, the aggregate value of Public Warrants was $383,333.
The estimated fair value of the Private Placement Warrants on September 30, 2022 is determined using Level 3 inputs. Inherent in a Monte-Carlo simulation model are assumptions related to expected stock-price volatility (pre-merger and post-merger), expected term, dividend yield and risk-free interest rate. The Company estimates the volatility of its common stock based on management’s understanding of the volatility associated with instruments of other similar entities. The risk-free interest rate is based on the U.S. Treasury Constant Maturity similar to the expected remaining life of the warrants. The expected life of the warrants is simulated based on management assumptions regarding the timing and likelihood of completing a Business Combination. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero. The assumptions used in calculating the estimated fair values represent the Company’s best estimate. However, inherent uncertainties are involved. If factors or assumptions change, the estimated fair values could be materially different.
The key inputs into the Black Scholes model for the Private Placement Warrants were as follows:
Input September 30,
2022 December 31,
2021
Expected term (years) 5.25 5.25
Expected volatility 0.9 % 11.0 %
Risk-free interest rate 3.00 % 1.35 %
Stock price $ 9.89 $ 9.25
Dividend yield 0.00 % 0.00 %
Exercise price $ 11.50 $ 11.50

The following table sets forth a summary of the changes in the fair value of the Level 3 warrant liability for the three and nine months September 30, 2022:
Warrant
Liability
Fair value as of December 31, 2021 $ 3,255,000
Change in fair value (2,066,667 )
Fair value as of March 31, 2022 $ 1,188,333
Change in fair value (620,000 )
Fair value as of June 30, 2022 $ 568,333
Change in fair value (361,667 )
Fair value as of September 30, 2022 $ 206,667
Working Capital Notes
The Company established the fair value for the Working Capital Note I using a Black-Scholes model, which is considered to be a Level 3 fair value measurement.
The estimated fair value of the Working Capital Notes was based on the following significant inputs:
Input December 31,
2021 September 30,
2022
Expected term (years) 5.25 5.25
Expected volatility 11.0 % 0.9 %
Risk-free interest rate 1.35 % 3.0 %
Stock price $ 9.25 9.89
Dividend yield 0.00 % 0.00 %
Exercise price $ 11.50 11.50
The following table presents the changes in the fair value of the Level 3 Working Capital Note I:
Fair value as of January 1, 2022 $ —
Proceeds received through issuance of Working Capital Notes 600,000
Capital contribution attributable to proceeds received in excess of fair value of Working Capital Notes 250,000
Change in valuation inputs or other assumptions (334,000 )
Fair value as of September 30, 2022 $ 16,000
There were no transfers in or out of Level 3 from other levels in the fair value hierarchy during the three months ended September 30, 2022 for Working Capital Note I.
Recurring Fair Value Measurements
The following table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of ~~March 31, 2021,~~September 30, 2022 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.
March 31, Quoted
Prices In
Active
Markets Significant
Other
Observable
Inputs Significant
Other
Unobservable
Inputs
2021 (Level 1) (Level 2) (Level 3)
Assets:
U.S. Money Market held in Trust Account $ 522 $ 522 $ - $ -
U.S. Treasury Securities held in Trust Account $ 287,517,925 $ 287,517,925 - -
$ 287,518,447 $ 287,518,447 $ - $ -
Liabilities:
Public Warrant Liability $ 5,941,666 $ 5,941,666 $ - $
Private Warrant Liability $ 4,958,334 $ $ - $ 4,598,334
$ 10,540,000 $ 5,941,666 $ 4,598,334
15
September 30, Quoted
Prices In
Active
Markets Significant
Other
Observable
Inputs Significant
Other
Unobservable
Inputs
2022 (Level 1) (Level 2) (Level 3)
Assets:
U.S. Money Market held in Trust Account $ 2,627 $ 2,627 $ — $ —
U.S. Treasury Securities held in Trust Account 289,148,327 289,148,327 — —
$ 289,150,954 $ 289,150,954 $ — $ —
Liabilities:
Public Warrant Liability $ 383,333 $ 383,333 $ — $ —
Private Warrant Liability 206,667 — — 206,667
Working Capital Notes 16,000 — — 16,000
$ 606,000 $ 383,333 $ — $ 222,667

NOTE 7 - COMMITMENTS AND CONTINGENCIES
~~Note 8 — Commitments and Contingencies~~
Registration Rights
The holders of the ~~founder shares,~~Founder Shares, Private Placement Warrants, and ~~warrants that may be issued upon conversion of Working Capital Loans will~~Conversion Warrants have registration rights to require the Company to register a sale of any of its securities held by them pursuant to a registration rights agreement signed on January 28, 2021. These holders ~~will be~~are entitled to make up to three demands, excluding short form registration demands, that the Company registers such securities for sale under the Securities Act. In addition, these holders ~~will~~ have “piggy-back” registration rights to include their securities in other registration statements filed by the Company.
Underwriting Agreement
The underwriters ~~have~~had a 45-day option from February 2, 2021 to purchase up to an additional 3,750,000 Units to cover ~~over-allotments, if any.~~over-allotments.
On February 2, 2021, the underwriters fully exercised the over-allotment option to purchase 3,750,000 Units and paid a fixed underwriting discount in the aggregate of $5,750,000. Additionally, the underwriters ~~will be~~are entitled to a deferred underwriting discount of 3.5% of the gross proceeds of the IPO held in the Trust Account, or $10,062,500, upon the completion of the Company’s ~~initial~~ Business Combination subject to the terms of the underwriting agreement.
NOTE 8 - STOCKHOLDERS’ EQUITY (DEFICIT)
~~Note 9 — Stockholder’s Equity~~
Preferred Stock—
The Company is authorized to issue a total of 10,000,000 preferred shares at par value of $0.0001 each. ~~At March 31, 2021~~As of September 30, 2022 and December 31, ~~2020,~~2021, there were no shares of preferred stock issued or outstanding.
Class A Common Stock—
The Company is authorized to issue a total of 320,000,000 shares of Class A common ~~shares~~stock at par value of $0.0001 each. As of ~~March 31, 2021~~September 30, 2022 and December 31, ~~2020,~~2021, there were ~~2,415,836 and 0~~no shares of Class A common stock issued and outstanding, excluding ~~26,334,164 and 0~~28,750,000 shares of Class A common stock subject to possible ~~redemption, respectively.~~redemption.
Class B Common Stock—
The Company is authorized to issue a total of 20,000,000 shares of Class B common ~~shares~~stock at par value of $0.0001 each. In November 2020, the Company’s ~~initial stockholders~~Initial Stockholders purchased an aggregate of 7,187,500 ~~founder shares~~Founder Shares for a capital contribution of $25,000. The ~~founder shares include~~Founder Shares included an aggregate of up to 937,500 shares subject to forfeiture if the over-allotment option iswas not exercised by the underwriters in full. Because of the underwriters’ ~~fully~~full exercise of the over-allotment option on February 2, 2021, 937,500 shares are no longer subject to forfeiture. ~~At March 31, 2021~~As of September 30, 2022 and December 31, ~~2020,~~2021, there were 7,187,500 shares of Class B common ~~shares (the "Founder Shares")~~stock issued and outstanding.
The Company’s Sponsor, directors and officers have agreed not to transfer, assign or sell their ~~founder shares~~Founder Shares until the earlier to occur of (A) one year after the completion of the Company’s ~~initial~~ Business Combination or (B) subsequent to the Company’s ~~initial~~ Business Combination, (x) if the reported closing price of the Company’s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s ~~initial~~ Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, or other similar transaction that results in all of its stockholders having the right to exchange their shares of common stock for cash, securities or other property.
The shares of Class B common stock will automatically convert into shares of the Company’s Class A common stock at the time of its ~~initial~~ Business Combination on a one-for-one basis, subject to adjustment pursuant to certain anti-dilution rights, as described herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the Company’s ~~initial~~ Business Combination, the number of shares of Class A common stock issuable upon conversion of all ~~founder shares~~Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the IPO, plus the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the ~~initial~~ Business Combination, excluding any shares of Class A common stock or equity-linked securities exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the ~~initial~~ Business Combination and any private placement-equivalent warrants issued to the Company’s Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of ~~founder shares~~Founder Shares will never occur on a less than one for one basis.
Holders of record of the Class A ~~common stock~~ and ~~holders of record of the~~ Class B common stock ~~will~~ vote together as a single class on all matters submitted to a vote of the Company’s stockholders, with each share of common stock entitling the holder to one vote except as required by law.
NOTE 9 - SUBSEQUENT EVENTS
~~Note 10 — Subsequent Events~~
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the accompanying unaudited condensed financial statements were available to be issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the accompanying unaudited condensed financial statements.
On November 10, 2022, the Company filed a definitive proxy statement with the SEC and plans to hold a stockholder meeting on December 7, 2022 to seek approval of the following proposals: the Redemption Limit Elimination Proposal, the Early Termination Proposal, the Early Termination Trust Amendment Proposal and the Adjournment Proposal. If the proposals are approved by the stockholders, the Company plans to liquidate in advance of the mandatory liquidation date in the current amended and restated certificate of incorporation and no later than December 30, 2022, and distribute the funds held in Trust Account to the Public Stockholders.
16

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF ~~OPERATIONS~~OPERATIONS.

References to the “Company,” “us,” “our” or “we” refer to Clarim Acquisition Corp. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed financial statements and related notes included herein.
Cautionary Note Regarding Forward-Looking Statements

All statements other than statements of historical fact included in this Report including, without limitation, statements under this ~~“Management’s~~“Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding ~~the Company’s~~our financial position, business strategy and the plans and objectives of management for future operations, are forward- looking statements. When used in this Report, words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us or the Company’s management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, ~~the Company’s~~our management. Actual results could differ materially from those contemplated by the forward- looking statements as a result of certain factors detailed in our filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on ~~the Company’s~~our behalf are qualified in their entirety by this paragraph.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Overview

We are ~~an early-stage~~a blank check company incorporated as a Delaware corporation ~~and~~on November 4, 2020. The Company was formed for the purpose of effecting ~~an initial business combination.~~a Business Combination with one or more businesses.

We leverage the more than nine decades of combined operational and financial experience of our management team and board of directors who are both established e-commerce entrepreneurs and sophisticated investors. We believe our extensive industry experience and proven ability to source, acquire, grow and revitalize companies will provide our management team with a robust and consistent flow of acquisition opportunities. Our management team and board’s broad relationships across multiple networks, including leading consumer and technology company founders, executives of private and public companies, leading M&A investment banks and private equity firms, as well as their ability to engage early with founder-led businesses represents a differentiated advantage to successfully source transaction opportunities. Our team has been immersed in the same ecosystem as the current founders of private companies who are making decisions on how to build currency for future growth and monetization.

While we may pursue an initial ~~business combination~~Business Combination target in any business, industry or geographical location, we are focusing our search primarily within the consumer-facing e-commerce sector. We are capitalizing on the ability of our management team to identify, acquire and operate a business or businesses that can benefit from our management team and board’s established relationships and operating experience. Our management team has extensive experience in identifying and executing strategic investments and has done so successfully in several sectors, particularly in digital consumer-facing businesses. Over time, we believe that all companies will need to deploy an omni-commerce strategy to succeed, and we will leverage our management team and board’s unique experience to successfully develop our business target’s omni-commerce.

17

Results of Operations

Our entire activity since inception up to ~~March 31, 2021~~September 30, 2022 relates to our formation, the ~~Initial Public Offering~~IPO and, since the closing of the ~~Initial Public Offering,~~IPO, a search for aan initial Business Combination candidate. We will not ~~be generating~~generate any operating revenues until the closing and completion of our initial Business Combination, at the earliest. We generate non-operating income in the form of interest income on marketable securities held after the IPO. We incur expenses as a result of being a public company (for legal, financial reporting, accounting, and auditing compliance), as well as for due diligence expenses in connection with completing an initial Business Combination.

For the three months ended ~~March 31, 2021,~~September 30, 2022, we had net income of ~~$3,322,648,~~$1,963,645, which consisted of ~~18,447~~$1,222,941 in interest earned on marketable securities held in the Trust Account and $9$1,032,500 on change in fair value of warrants, $28,000 in the change in fair value of the Working Capital Notes, offset by $247,783 in operating costs.
For the nine months ended September 30, 2022, we had net income of $9,939,295, which consisted of $1,763,467 in interest earned on marketable securities held in the Trust Account and $8,702,500 on change in fair value of warrants, $334,000 in the change in fair value of the Working Capital Notes, offset by $783,650 in operating costs.
For the three months ended September 30, 2021, we had net income of $1,738,856, which consisted of $23,672 in interest earned on marketable securities held in the Trust Account, and $16 in bank interest income, and ~~$4,018,333~~$3,149,167 in unrealized gain on change in fair value of warrants, offset by ~~$184,082~~$1,433,999 in operating costs which included accrued professional expenses for identifying targets, pursuing discussions with potential acquisition candidates, due diligence of prospective business combination partners and initial negotiations regarding deal terms for potential transactions.
For the nine months ended September 30, 2021, we had net income of $2,932,458, which consisted of $58,584 in interest earned on marketable securities held in the Trust Account, and $43 in bank interest income, and $5,413,333 in unrealized gain on change in fair value of warrants, offset by $1,433,999 in operating costs and $530,059 inof warrant issuance costs.

Liquidity, ~~and~~ Capital Resources and Going Concern

As of ~~March 31, 2021, we~~September 30, 2022, the Company had ~~approximately $0.7 million~~$154,266 in ~~our~~its operating bank account, and a working capital deficit of ~~approximately $1.4 million.~~$824,765.

Prior to the completion of the ~~Initial Public Offering,~~IPO, our liquidity needs had been satisfied through a payment from the Sponsor of $25,000 for the ~~founder shares~~Founder Shares to cover certain offering costs, and the loan under an unsecured promissory note from the Sponsor of $112,942. We ~~fully~~ paid $112,500 of the ~~note~~loan to the Sponsor on February 11, 2021. Subsequent to the consummation of the ~~Initial Public Offering~~IPO and Private Placement, our liquidity needs have been satisfied through the proceeds from the consummation of the Private Placement not held in the Trust ~~Account.~~Account and Working Capital Notes.

In addition, in order to finance transaction costs in connection with aan initial Business Combination, our Sponsor or an affiliate of the Sponsor or certain of our officers and directors may, but are not obligated to, provide us Working Capital Loans. ~~To date, there were no amounts outstanding under any~~
We also issued the Working Capital ~~Loans.~~
~~Based~~Notes to the Sponsor on November 19, 2021 and March 31, 2022, respectively, pursuant to which we may draw down capital to fund our working capital needs or in connection with our initial Business Combination, up to a total principal amount in the aggregate of up to $1,350,000. The Sponsor has also informally agreed to commit additional funding as and if necessary and agreed with us of up to $500,000 upon similar terms and conditions as the foregoing ~~management believes that we will have sufficient working capital and borrowing capacity to meet our needs~~promissory note. At September 30, 2022, an aggregate of $600,000 has been drawn against the Working Capital Notes.
Over this time period through the earlier of the consummation of aan initial Business Combination or one year from this ~~filing. Over this time period,~~filing, we will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the initial Business Combination.

The Company cannot guarantee that it will have sufficient resources to execute its business plan. Accordingly, the Company may need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms. As of the date of this Report, the Company is within 12 months of its mandatory liquidation date of February 2, 2023. In connection with the Company’s assessment of going concern considerations in accordance with ASU Topic 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going concern.
No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after February 2, 2023.
On November 10, 2022, the Company filed a definitive proxy statement with the SEC and plans to hold a stockholder meeting on December 7, 2022 to seek approval of the following proposals: the Redemption Limit Elimination Proposal, the Early Termination Proposal, the Early Termination Trust Amendment Proposal and the Adjournment Proposal. If the proposals are approved by the stockholders, the Company plans to liquidate in advance of the mandatory liquidation date in the current amended and restated certificate of incorporation and no later than December 30, 2022, and distribute the funds held in Trust Account to the Public Stockholders.

Off-Balance Sheet Arrangements
As of September 30, 2022, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.
Contractual Obligations
We do not have any long-term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or other long-term liabilities, other than an agreement to pay the Sponsor a monthly fee of $10,000 for office space, utilities and secretarial and administrative support. We began incurring these fees on January 28, 2021 and will continue to incur these fees monthly until the earlier of the completion of our initial Business Combination or our liquidation.
The underwriters of the IPO are entitled to a deferred underwriting commission of 3.5% of the gross proceeds of the IPO held in the Trust Account, or $10,062,500, upon the completion of our initial Business Combination, subject to the terms of the underwriting agreement. The deferred underwriting commission will be waived by the underwriters in the event that we do not complete an initial Business Combination.
Critical Accounting Policies and Estimates

The preparation of the ~~unaudited condensed~~ financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the accompanying unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. We have identified the following as our critical accounting policies:

Common Stock Subject to Possible Redemption

~~The Company accounts~~We account for ~~its~~our common stock subject to possible redemption in accordance with the guidance in ~~Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”~~ASC 480. Common stock subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within ~~the Company’s~~our control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ ~~equity. The Company’s~~deficit. Our common stock feature certain redemption rights that isare considered to be outside of ~~the Company’s~~our control and subject to the occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ ~~equity~~deficit section of ~~the Company’s~~our balance ~~sheet.~~sheets.

We recognize changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit.
18
Net Income per Common stock
We have two classes of shares, which are referred to as “Class A common stock” and “Class B common stock.” Earnings and losses are shared pro rata between the two classes of shares. The 14,750,000 potential common stock for outstanding warrants to purchase our stock were excluded from diluted earnings per share for the three and nine months ended September 30, 2022 because the warrants are contingently exercisable, and the contingencies have not yet been met.
Offering Costs associated with the Initial Public Offering
We comply with the requirements of ASC 340-10-S99-1 and SAB 5A. Offering costs consist principally of professional and registration fees incurred through the balance sheet date. Offering costs are allocated to the separable financial instruments issued in the IPO based on a relative fair value basis compared to total proceeds received. Offering costs associated with warrant liabilities is expensed, and offering costs associated with the Class A common stock were charged to temporary equity upon the completion of the IPO.

~~Net Income Per Common Share~~Derivative Financial Instruments

~~Net income per common share is computed by dividing net income by~~We evaluate our financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815. Derivative instruments are recorded at fair value on the ~~weighted average number~~grant date and re-valued at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are classified on the balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. We have determined the warrants are a derivative instrument.
FASB ASC Topic 470-20 “Debt with Conversion and Other Options,” addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. We apply this guidance to allocate IPO proceeds from the Units between Class A common stock ~~outstanding for each of~~and warrants, using the ~~periods. The calculation of diluted income per common share does not consider the effect~~residual method by allocating IPO proceeds first to fair value of the warrants ~~issued~~and then the Class A common stock.
Working Capital Notes
We account for the Working Capital Notes, which are convertible promissory notes, under ASC 815. Under ASC 815-15-25, the election can be at the inception of a financial instrument to account for the instrument under the fair value option under ASC 825. We have made such election for the Working Capital Notes. Using the fair value option, the Working Capital Notes are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in ~~connection with~~ the ~~(i) IPO, (ii) exercise of overallotment and (iii) Private Placement since the exercise~~estimated fair value of the ~~warrants~~notes are ~~contingent upon the occurrence~~recognized as a non-cash gain or loss in our condensed statements of ~~future events and the inclusion of such warrants would be anti-dilutive. The warrants~~operations.
Emerging Growth Company Status
We are ~~exercisable to purchase 14,750,000 shares of common stock in the aggregate.~~
~~Off-Balance Sheet Arrangements~~
~~As of March 31, 2021, we did not have any off-balance sheet arrangements~~an “emerging growth company,” as defined in ~~Item 303(a)(4)(ii)~~Section 2(a) of ~~Regulation S-K.~~the Securities Act, as modified by the JOBS Act, and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and approval of any golden parachute payments not previously approved.
Further, Section102 (b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. We have elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Factors That May Adversely Affect Our Results of Operations
Our results of operations and our ability to complete an initial Business Combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond our control. Our business could be impacted by, among other things, downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence and spending, the ongoing effects of the COVID-19 pandemic, including resurgences and the emergence of new variants, and geopolitical instability, such as the military conflict in the Ukraine. We cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact our business and our ability to complete an initial Business Combination.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET ~~RISK~~RISK.

~~Not required for~~We are a smaller reporting ~~companies.~~company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

ITEM 4. CONTROLS AND ~~PROCEDURES~~PROCEDURES.

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures designed to ensure that information required to be disclosed ~~by us~~ in our reports filed or submitted under the Exchange Act ~~reports~~ is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and ~~forms,~~forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that ~~such~~ information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to ~~our~~ management, including our ~~principal executive officer~~Chief Executive Officer and ~~principal financial officer~~Chief Financial Officer (together, the “Certifying Officers”), or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our ~~chief executive officer,~~Certifying Officers, we ~~conducted~~carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as ~~of the end of the fiscal quarter ended March 31, 2021, as such term is~~ defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based ~~upon that evaluation, and in light of~~on the ~~SEC’s Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies, promulgated on April 12, 2021,~~foregoing, our ~~chief financial officer (who serves as our principal financial officer) has~~Certifying Officers concluded that ~~solely due to the Company’s restatement of its financial statements to reclassify the Company’s warrants as described in Note 2, a material weakness existing and~~ our disclosure controls and procedures were not effective as of ~~March 31, 2021.~~the end of the period covered by this Report, due solely to the material weakness in our internal control over financial reporting related to our accounting for complex financial instruments.

In light of this material weakness, we have enhanced our processes to identify and appropriately apply applicable accounting requirements to better evaluate and understand the nuances of the complex accounting standards that apply to our financial statements including making greater use of third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects. We believe our efforts will enhance our controls relating to accounting for complex financial transactions, but we can offer no assurance that our controls will not require additional review and modification in the future as industry accounting practice may evolve over time.
We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Changes in Internal Control over Financial Reporting

~~During the most recently completed fiscal quarter ended March 31, 2021,~~Other than as discussed above, there ~~was~~have been no ~~change in~~changes to our internal control over financial reporting during the quarter ended September 30, 2022 that ~~has~~ materially affected, or isare reasonably likely to materially affect, our internal control over financial reporting.

19

PART II – OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS.

~~None.~~To the knowledge of our management team, there is no litigation currently pending or contemplated against us, any of our officers or directors in their capacity as such or against any of our property.
ITEM 1A. RISK FACTORS.

~~Other~~As of the date of this Report, other than ~~disclosed~~as set forth below, there have been no material changes ~~from the~~with respect to those risk factors previously disclosed in our (i) Registration Statement, (ii) Annual Report on Form 10-K for the ~~Company’s final prospectus,~~year ended December 31, 2021, as filed with the SEC on ~~February 1, 2021.~~
~~Our warrants are accounted~~April 15, 2022 and (iii) Quarterly Reports on Form 10-Q for the quarters ended March 31, 2021, September 30, 2021, March 31, 2022 and June 30, 2022, as ~~liabilities~~filed with the SEC on May 24, 2021, November 22, 2021, May 23, 2022, and ~~the changes~~August 16, 2022 respectively. Any of these factors could result in ~~value of our warrants could have~~ a significant or material adverse effect on our ~~financial results.~~
On April 12, 2021, the Acting Director of the Division of Corporation Finance and Acting Chief Accountant of the SEC together issued a statement regarding the accounting and reporting considerations for warrants issued by special purpose acquisition companies entitled “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (the “SEC Statement”). Specifically, the SEC Statement focused on certain settlement terms and provisions related to certain tender offers following a business combination, which terms are similar to those contained in the warrant agreement governing our warrants.
As a result, included on our balance sheet as of March 31, 2021 contained elsewhere in this report are derivative liabilities related to embedded features contained within our warrants. Accounting Standards Codification 815, Derivatives and Hedging (“ASC 815”) provides for the remeasurement of the fair value of such derivatives at each balance sheet date, with a resulting non-cash gain or loss related to the change in the fair value being recognized in earnings in the statements of operations. As a result of the recurring fair value measurement, our financial statements and results of operations or financial condition. Additional risks could arise that may ~~fluctuate quarterly based on factors which are outside of~~also affect our ~~control. Due to the recurring fair value measurement, we expect that we will recognize non-cash gains~~business or ~~losses on our warrants each reporting period and that the amount of such gains or losses could be material.~~
Warrants that are accounted for as a warrant liability will be recorded at fair value upon issuance with changes in fair value each period reported in earnings, which may have an adverse effect on the market price of our common stock and/or may make it more difficult for usability to consummate an initial ~~business combination.~~Business Combination. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.

~~We account~~A new 1% U.S. federal excise tax could be imposed on us in connection with future redemptions by public stockholders of our shares.
On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic corporations and certain domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the ~~14,750,000 warrants issued~~repurchasing corporation itself, not its stockholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.
Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the ~~initial public offering (including~~Business Combination, extension or otherwise, (ii) the ~~9,583,333 warrants sold as part~~structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the U.S. Department of the ~~units~~Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the ~~initial public offering~~cash available on hand to complete a Business Combination and in the 5,166,667 private placement warrants) in accordance with the guidance contained in Derivatives and Hedging — Contracts in Entity’s Own Equity (ASC 815-40). Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded asCompany’s ability to complete a liability. Accordingly, we will classify each warrant as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each such remeasurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in our statement of operations and therefore our reported earnings. The impact of changes in fair value on earnings may have an adverse effect on the market price of our common stock. In addition, potential targets may seek a SPAC that does not have warrants that are accounted for as a warrant liability, which may make it more difficult for us to consummate an initial business combination with a target business.Business Combination.
We have identified a material weakness in our internal control over financial reporting as of March 31, 2021. If we are unable to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results in a timely manner, which may adversely affect investor confidence in us and materially and adversely affect our business and operating results.
Following the issuance of the SEC Staff Statement, our management - concluded that, in light of the SEC Staff Statement, our audited balance sheet as of February 2, 2021 should no longer be relied upon. In connection with the foregoing development, we identified a material weakness in our internal controls over financial reporting.

20

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented, or detected and corrected on a timely basis.
Effective internal controls are necessary for us to provide reliable financial reports and prevent fraud. We continue to evaluate steps to remediate the material weakness. These remediation measures may be time consuming and costly and there is no assurance that these initiatives will ultimately have the intended effects.
If we identify any new material weaknesses in the future, any such newly identified material weakness could limit our ability to prevent or detect a misstatement of our accounts or disclosures that could result in a material misstatement of our annual or interim financial statements. In such case, we may be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports in addition to applicable stock exchange listing requirements, investors may lose confidence in our financial reporting and our stock price may decline as a result. We cannot assure you that the measures we have taken to date, or any measures we may take in the future, will be sufficient to avoid potential future material weaknesses.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

~~Use of Proceeds~~
On ~~February 2, 2021, we consummated our initial public offering of~~ ~~28,750,000~~ ~~units, including 3,750,000 units issued pursuant to the exercise~~None. For a description of the ~~underwriters’ over-allotment option~~use of proceeds generated in ~~full. Each unit consists~~our Initial Public Offering and Private Placement, see Part II, Item 2 of ~~one share of Class A common stock, par value $0.0001 per share, and one-third of one redeemable warrant, with each whole warrant entitling~~our Quarterly Report on Form 10-Q for the ~~holder thereof to purchase one share of Class A common stock for $11.50 per share.~~
~~The units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $287,500,000~~. ~~On February 2,~~quarter ended March 31, 2021, ~~simultaneously~~as filed with the consummation of our initial public offering, we completed the private sale of an aggregate of 5,166,667 warrants at a purchase price of $1.50 per private placement warrant, to Clarim Partners, LLC (“Sponsor”), generating gross proceeds of $7,750,000.
~~Following the closing of our initial public offering~~SEC on February 2, 2021, a total of $287,500,000 comprised of $281,750,000 of the proceeds from the IPO and $5,750,000 of the proceeds of the sale of the Private Placement Warrants, was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee. The proceeds held in the trust account may be invested by the trustee only in U.S. government securities with a maturity of 185 days or less or in money market funds investing solely in U.S. government treasury obligations and meeting certain conditions under Rule 2a-7 under the Investment Company Act, as amended.
May 24, 2021. There has been no material change in the planned use of ~~the~~ proceeds from our ~~initial public offering~~IPO and ~~the private placement~~Private Placement as is described in the ~~Company’s final prospectus related to our initial public offering.~~Registration Statement.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.
ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.
ITEM 5. OTHER INFORMATION.

None.

21

ITEM 6. EXHIBITS.

The following exhibits are filed as part of, or incorporated by reference into, this ~~Quarterly Report on Form 10-Q.~~Report.

No. Description of Exhibit
31.1*
Certification of the Principal Executive Officer ~~Pursuant~~pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act ~~Rules 13a-14(a) and 15(d)-14(a),~~of 1934, as adopted ~~Pursuant~~pursuant to Section 302 of the Sarbanes-Oxley Act of ~~2002~~2002.*
31.2* Certification of the Principal Financial Officer ~~Pursuant~~pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act ~~Rules 13a-14(a) and 15(d)-14(a),~~of 1934, as adopted ~~Pursuant~~pursuant to Section 302 of the Sarbanes-Oxley Act of ~~2002~~2002.*
32.1** Certification of the Principal Executive Officer ~~Pursuant~~pursuant to 18 U.S.C. ~~Section~~ 1350, as adopted ~~Pursuant~~pursuant to Section 906 of the Sarbanes-Oxley Act of ~~2002~~2002.
32.2** Certification of the Principal Financial Officer ~~Pursuant~~pursuant to 18 U.S.C. ~~Section~~ 1350, as adopted ~~Pursuant~~pursuant to Section 906 of the Sarbanes-Oxley Act of ~~2002~~2002.
101.INS* Inline XBRL Instance ~~Document~~Document.
101.CAL*101.SCH* Inline XBRL Taxonomy Extension Schema Document.
101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase ~~Document~~Document.
101.SCH*101.DEF* ~~XBRL Taxonomy Extension Schema Document~~
101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase ~~Document~~Document.
101.LAB* Inline XBRL Taxonomy Extension ~~Labels~~Label Linkbase ~~Document~~Document.
101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase ~~Document~~
* ~~Filed herewith.~~Document.
**104* ~~Furnished.~~ Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

* 22Filed herewith.
** Furnished herewith.

~~SIGNATURE~~
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned ~~hereunto~~thereunto duly authorized.

Dated: ~~May 21, 2021~~November 14, 2022 CLARIM ACQUISITION CORP.

By: /s/ James F. McCann
James F. McCann

Chief Executive Officer and

Chairman of the Board
(Principal Executive Officer)

Dated: ~~May 21, 2021~~November 14, 2022 By: /s/ Jaymin Patel
Jaymin Patel
Chief Financial Officer, President and Director
(Principal Accounting and Financial ~~and Accounting~~ Officer)

23
28
25274725 28750000 28750000 28750000 0.05 0.05 0.09 0.28 7074176 7187500 7187500 7187500 0.05 0.05 0.09 0.28 0.05 0.05 0.05 0.05 0.09 0.09 0.28 0.28 false --12-31 Q3 0001831937 iso4217:USD xbrli:shares

	March 31, 2021		December 31, 2020
	(unaudited)
Assets
Current asset - Cash	$	721,945	$	-
Prepaid expenses		733,275		-
Deferred offering costs		-		106,575
Total current assets		1,455,220		106,575
Cash and securities held in Trust Account		287,518,447		-
Total Assets	$	288,973,667	$	106,575

Liabilities and Stockholders’ Equity
Current liabilities:
Accrued offering costs and expenses	$	26,075	$	1,430
Due to related party		3,000		-
Promissory note - related party		442		81,575
Total current liabilities		29,517		83,005
Warrant liability		10,540,000		-
Deferred underwriting discount		10,062,500		-
Total liabilities		20,632,017		83,005

Commitments and Contingencies
Class A common stock subject to possible redemption, 26,334,164 shares and 0 shares at redemption value at March 31, 2021 and December 31, 2020, respectively		263,341,640		-

Stockholders’ Equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; none issued and outstanding		-		-
Class A common stock, $0.0001 par value; 320,000,000 shares authorized; 2,415,836 shares and 0 shares issued and outstanding (excluding 26,334,164 shares and 0 shares subject to possible redemption) at March 31, 2020 and December 31, 2020, respectively		242		-
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 7,187,500 and 7,187,500 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively		719		719
Additional paid-in capital		1,677,831		24,281
Retained earnings (accumulated deficit)		3,321,218		(1,430	)
Total stockholders’ equity		5,000,010		23,570
Total Liabilities and Stockholders’ Equity	$	288,973,667	$	106,575

	September 30, 2022			December 31, 2021
	(Unaudited)
Assets
Current asset - cash	$	154,266		$	107,125
Prepaid expenses		150,690			392,500
Total current assets		304,956			499,625
Prepaid expenses, non-current		—			31,185
Cash and marketable securities held in Trust Account		289,150,954			287,589,794
Total Assets	$	289,455,910		$	288,120,604

Liabilities, Redeemable Common Stock and Stockholders’ Deficit
Current liabilities:
Accounts payable and accrued expenses	$	131,270		$	332,927
Income taxes payable		77,022			—
Accrued franchise tax		150,000			200,000
Due to related party		8,000			8,000
Sponsor IPO Loan		442			442
Working Capital Notes		16,000			—
Accrued professional fees		746,987			739,841
Total current liabilities		1,129,721			1,281,210
Warrant liabilities		590,000			9,292,500
Deferred underwriting discount		10,062,500			10,062,500
Total liabilities		11,782,221			20,636,210

Commitments and Contingencies
Redeemable Common Stock
Class A common stock subject to possible redemption, 28,750,000 shares at redemption value		288,924,183			287,500,000

Stockholders’ Deficit:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; none issued and outstanding		—			—
Class A common stock, $0.0001 par value; 320,000,000 shares authorized;		—			—
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 7,187,500 shares issued and outstanding		719			719
Additional paid-in capital		250,000			—
Accumulated deficit		(11,501,213	)		(20,016,325	)
Total stockholders’ deficit		(11,250,494	)		(20,015,606	)
Total Liabilities, Redeemable Common Stock and Stockholders’ Deficit	$	289,455,910		$	288,120,604

	For the Three Months Ended March 31, 2021
Operating costs	$	184,082
Loss from operations		(184,082	)

Other income (expense)
Unrealized gain on change in fair value of warrants		4,018,333
Bank interest income		9
Trust interest income		18,447
Warrant issuance costs		(530,059	)
Total other income		3,506,730

Net income	$	3,322,648

Basic and diluted weighted average shares outstanding, common stock subject to redemption		16,433,702
Basic and diluted net income per share	$	-

Basic and diluted weighted average shares outstanding, common stock		8,962,131
Basic and diluted net income per share	$	0.37

	Three Months Ended September 30,						Nine Months Ended September 30,
	2022			2021			2022			2021

Operating costs	$	247,783		$	1,433,999		$	783,650		$	2,009,443
Loss from operations		(247,783	)		(1,433,999	)		(783,650	)		(2,009,443	)

Other income:
Change in fair value of warrant liabilities		1,032,500			3,149,167			8,702,500			5,413,333
Change in fair value of Working Capital Notes		28,000			-			334,000			-
Bank interest income		-			16			-			43
Interest income on marketable securities held in Trust Account		1,222,941			23,672			1,763,467			58,584
Warrant issuance costs		-			-			-			(530,059	)
Total other income, net		2,283,441			3,172,855			10,799,967			4,941,901

Income before provision for income taxes		2,035,658			1,738,856			10,016,317			2,932,458
Provision for income taxes		72,013			-			77,022			-
Net income	$	1,963,645		$	1,738,856		$	9,939,295		$	2,932,458

Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption		28,750,000			28,750,000			28,750,000			25,274,725
Basic and diluted net income per share, Class A common stock subject to possible redemption	$	0.05		$	0.05		$	0.28		$	0.09

Basic and diluted weighted average shares outstanding, Class B, non-redeemable common stock		7,187,500			7,187,500			7,187,500			7,074,176
Basic and diluted net income per share, Class B, non-redeemable common stock		0.05			0.05			0.28			0.09

	Class A Common Stock						Class B Common Stock				Additional Paid-in			Retained			Total Stockholders'
	Shares			Amount			Shares		Amount		Capital			Earnings			Equity
Balance as of December 31, 2020		-		$	-			7,187,500	$	719	$	24,281		$	(1,430	)	$	23,570
Sale of 25,000,000 Units through IPO		25,000,000			2,500			-		-		249,997,500			-			250,000,000
Sale of 3,750,000 Units on through over-allotment		3,750,000			375			-		-		37,499,625			-			37,500,000
Sale of 5,166,667 Private Placement Warrants		-			-			-		-		7,750,000			-			7,750,000
Underwriting fee		-			-			-		-		(5,750,000	)		-			(5,750,000	)
Deferred underwriting fee		-			-			-		-		(10,062,500	)		-			(10,062,500	)
Offering costs charged to the stockholders’ equity		-			-			-		-		(413,794	)		-			(413,794	)
Initial classification of warrant liability		-			-			-		-		(14,558,333	)		-			(14,558,333	)
Reclassification of offering costs related to warrants		-			-			-		-		530,059			-			530,059
Net income		-			-			-		-		-			3,322,648			3,322,648
Change in Class A common stock subject to possible redemption		(26,334,164	)		(2,633	)		-		-		(263,339,007	)		-			(263,341,640	)

Balance as of March 31, 2021		2,415,836		$	242			7,187,500	$	719	$	1,677,831		$	3,321,218		$	5,000,010

	Class B Common Stock				Additional Paid-in		Accumulated			Stockholders’
	Shares		Amount		Capital		Deficit			Deficit
Balance as of December 31, 2021		7,187,500		719		—		(20,016,325	)	$	(20,015,606	)

Net income		—		—		—		6,082,039			6,082,039
Balance as of March 31, 2022		7,187,500	$	719	$	—	$	(13,934,286	)	$	(13,933,567	)

Capital contribution attributable to proceeds received in excess of fair value of Working Capital Notes		—		—		250,000		—			250,000

Remeasurement of Class A common stock subject to possible redemption to redemption value		—		—		—		(322,255	)		(322,255	)

Net income		—		—				1,893,611			1,893,611
Balance as of June 30, 2022		7,187,500	$	719	$	250,000	$	(12,362,930	)	$	(12,112,211	)

Remeasurement of Class A common stock subject to possible redemption to redemption value								(1,101,928	)		(1,101,928	)
Net income		—		—		—		1,963,645			1,963,645
Balance as of September 30, 2022		7,187,500	$	719	$	250,000	$	(11,501,213	)	$	(11,250,494	)

	For the three months ended March 31, 2021

Cash flows from Operating Activities:
Net income	$	3,322,648
Adjustments to reconcile net income to net cash used in operating activities:
Warrant issuance costs		530,059
Decrease in fair value of warrants		(4,018,333	)
Interest earned on cash and marketable securities held in Trust Account		(18,447	)
Changes in current assets and current liabilities:
Prepaid expenses		(733,275	)
Accrued offering costs and expenses		162,587
Due to related party		3,000
Net cash used in operating activities		(751,761	)

Cash Flows from Investing Activities:
Investment in Trust Account		(287,500,000	)
Net cash used in investing activities		(287,500,000	)

Cash flows from Financing Activities:
Proceeds from Initial Public Offering, net of underwriters’ fees		281,750,000
Proceeds from private placement warrants		7,750,000
Repayment of promissory note to related party		(112,500	)
Payments of offering costs		(413,794	)
Net cash provided by financing activities		288,973,706

Net change in cash		721,945
Cash, beginning of the period		-
Cash, end of the period	$	721,945

Supplemental disclosure of noncash investing and financing activities:
Deferred underwriting commissions charged to additional paid in capital	$	10,062,500
Initial value of Class A common stock subject to possible redemption	$	259,479,510
Change in value of Class A common stock subject to possible redemption	$	3,862,130
Deferred offering costs paid by Sponsor loan	$	31,367
Initial classification of warrant liability at issuance	$	14,558,333

	For the Nine Months ended September 30,
	2022			2021

Cash flows from operating activities:
Net income	$	9,939,295		$	2,932,458
Adjustments to reconcile net income to net cash used in operating activities:
Warrant issuance costs		—			530,059
Change in fair value of warrant liabilities		(8,702,500	)		(5,413,333	)
Change in fair value of Working Capital Notes		(334,000	)		—
Interest earned on cash and marketable securities held in Trust Account		(1,763,467	)		(58,584	)
Changes in current assets and liabilities:
Prepaid expenses		272,995			(523,579	)
Deferred legal and professional fee					715,469
Accounts payable and accrued expenses		(201,657	)		552,580
Income taxes payable		77,022			—
Accrued franchise tax		(50,000	)		—
Accrued professional fees		7,146			—
Due to related party		—			8,000
Net cash used in operating activities		(755,166	)		(1,256,929	)

Cash Flows from Investing Activities:
Investment held in Trust Account		—			(287,500,000	)
Withdrawal from Trust Account to cover taxes		202,307
Net cash provided by (used in) investing activities		202,307			(287,500,000	)

Cash flows from financing activities:
Proceeds from Working Capital Notes		600,000			—
Proceeds from Initial Public Offering, net of underwriters’ fees		—			281,750,000
Proceeds from Private Placement Warrants		—			7,750,000
Repayment of Sponsor IPO Loan		—			(112,500	)
Payments of offering costs		—			(413,794	)
Net cash provided by financing activities		600,000			288,973,706

Net change in cash		47,141			216,777
Cash, beginning of the period		107,125			—
Cash, end of the period	$	154,266		$	216,777

Supplemental disclosures of noncash investing and financing activities:
Capital contribution for proceeds received in excess of fair value of Working Capital Notes	$	250,000		$	—
Remeasurement of Class A common stock subject to possible redemption to redemption value	$	1,424,183		$	25,087,901
Deferred underwriting commissions charged to additional paid in capital	$	—		$	10,062,500
Deferred offering costs paid by Sponsor loan	$	—		$	31,367
Initial fair value of warrant liability	$	—		$	14,558,333

	As Previously Reported			Adjustment			As Restated
Balance Sheet at February 2, 2021
Warrant Liability	$	-		$	14,558,333		$	14,558,333
Class A common stock subject to possible redemption		274,037,840			(14,558,330	)		259,479,510
Class A common stock		135			145			280
Additional paid-in capital		5,010,012			529,911			5,539,923
Accumulated deficit	$	(10,861	)	$	(530,059	)	$	(540,920	)

	For the Three Months Ended March 31, 2021
Common stock subject to possible redemption
Numerator: net income allocable to common stock subject to possible redemption
Interest income on marketable securities held in trust	$	16,897
Less: interest available to be withdrawn for payment of taxes		(16,897	)
Net income allocable to common stock subject to possible redemption	$	-
Denominator: Weighted average redeemable common stock
Redeemable common stock, basic and diluted		16,433,702
Basic and diluted net income per share, redeemable common stock	$	-

Non-redeemable common stock
Numerator: net income minus redeemable net earnings
Net income	$	3,322,648
Redeemable net earnings		-
Non-redeemable net income	$	3,322,648
Denominator: Weighted average non-redeemable basic and diluted weighted average shares outstanding, common stock		8,962,131
Basic and diluted net income per share, common stock	$	0.37

	For the three months ended September 30,								For the nine months ended September 30
	2022				2021				2022				2021
	Class A		Class B		Class A		Class B		Class A		Class B		Class A		Class B
Basic and diluted net income per share:
Numerator:
Allocation of net income	$	1,570,916		392,729	$	1,391,085		347,771	$	7,951,436		1,987,859	$	2,291,177		641,281
Denominator:
Weighted-average shares outstanding		28,750,000		7,187,500		28,750,000		7,187,500		28,750,000		7,187,500		25,274,725		7,074,176
Basic and diluted net income per share	$	0.05	$	0.05	$	0.05	$	0.05	$	0.28	$	0.28	$	0.09	$	0.09

Gross proceeds from IPO	$	287,500,000
Less:
Proceeds allocated to Public Warrants		(9,391,667	)
Issuance costs allocated to Class A common stock		(15,696,234	)
Plus:
Remeasurement of Class A common stock to redemption value		25,087,901
Class A common stock subject to possible redemption as of December 31, 2021		287,500,000
Plus:
Remeasurement of Class A common stock to redemption value		—
Class A common stock subject to possible redemption as of March 31, 2022		287,500,000
Plus:
Remeasurement of Class A common stock to redemption value		322,255
Class A common stock subject to possible redemption as of June 30, 2022	$	287,822,255
Plus:
Remeasurement of Class A common stock to redemption value		1,101,928
Class A common stock subject to possible redemption as of September 30, 2022	$	288,924,183

	Carrying Value/ Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value as of September 30, 2022
U.S. Money Market	$	2,627	$	—	$	—		$	2,627
U.S. Treasury Securities		289,148,327		—		(37,179	)		289,185,246
	$	289,150,954	$	—	$	(37,179	)	$	289,187,918

	Carrying Value/Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value as of March 31, 2021
U.S. Money Market	$	522	$	-	$	-	$	522
U.S. Treasury Securities		287,517,925		6,324		-		287,524,249
	$	287,518,447	$	6,324	$	-	$	287,524,771

Input	February 2, 2021
Expected term (years)		5.25
Expected volatility		18.40	%
Risk-free interest rate		0.67	%
Stock price	$	9.68
Dividend yield		0.00	%
Exercise price	$	11.50

	Warrant Liability
Fair value as of December 31, 2021	$	3,255,000
Change in fair value		(2,066,667	)
Fair value as of March 31, 2022	$	1,188,333
Change in fair value		(620,000	)
Fair value as of June 30, 2022	$	568,333
Change in fair value		(361,667	)
Fair value as of September 30, 2022	$	206,667

Fair value as of January 1, 2022	$	—
Proceeds received through issuance of Working Capital Notes		600,000
Capital contribution attributable to proceeds received in excess of fair value of Working Capital Notes		250,000
Change in valuation inputs or other assumptions		(334,000	)
Fair value as of September 30, 2022	$	16,000

	March 31,		Quoted Prices In Active Markets		Significant Other Observable Inputs		Significant Other Unobservable Inputs
	2021		(Level 1)		(Level 2)		(Level 3)
Assets:
U.S. Money Market held in Trust Account	$	522	$	522	$	-	$	-
U.S. Treasury Securities held in Trust Account	$	287,517,925	$	287,517,925		-		-
	$	287,518,447	$	287,518,447	$	-	$	-
Liabilities:
Public Warrant Liability	$	5,941,666	$	5,941,666	$	-	$
Private Warrant Liability	$	4,958,334	$		$	-	$	4,598,334
	$	10,540,000	$	5,941,666			$	4,598,334

	September 30,		Quoted Prices In Active Markets		Significant Other Observable Inputs		Significant Other Unobservable Inputs
	2022		(Level 1)		(Level 2)		(Level 3)
Assets:
U.S. Money Market held in Trust Account	$	2,627	$	2,627	$	—	$	—
U.S. Treasury Securities held in Trust Account		289,148,327		289,148,327		—		—
	$	289,150,954	$	289,150,954	$	—	$	—
Liabilities:
Public Warrant Liability	$	383,333	$	383,333	$	—	$	—
Private Warrant Liability		206,667		—		—		206,667
Working Capital Notes		16,000		—		—		16,000
	$	606,000	$	383,333	$	—	$	222,667

No.		Description of Exhibit
31.1*		Certification of the Principal Executive Officer ~~Pursuant~~pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act ~~Rules 13a-14(a) and 15(d)-14(a),~~of 1934, as adopted ~~Pursuant~~pursuant to Section 302 of the Sarbanes-Oxley Act of ~~2002~~2002.*
31.2*		Certification of the Principal Financial Officer ~~Pursuant~~pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act ~~Rules 13a-14(a) and 15(d)-14(a),~~of 1934, as adopted ~~Pursuant~~pursuant to Section 302 of the Sarbanes-Oxley Act of ~~2002~~2002.*
32.1**		Certification of the Principal Executive Officer ~~Pursuant~~pursuant to 18 U.S.C. ~~Section~~ 1350, as adopted ~~Pursuant~~pursuant to Section 906 of the Sarbanes-Oxley Act of ~~2002~~2002.
32.2**		Certification of the Principal Financial Officer ~~Pursuant~~pursuant to 18 U.S.C. ~~Section~~ 1350, as adopted ~~Pursuant~~pursuant to Section 906 of the Sarbanes-Oxley Act of ~~2002~~2002.
101.INS*		Inline XBRL Instance ~~Document~~Document.
101.CAL101.SCH		Inline XBRL Taxonomy Extension Schema Document.
101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase ~~Document~~Document.
101.SCH101.DEF		~~XBRL Taxonomy Extension Schema Document~~
101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase ~~Document~~Document.
101.LAB*		Inline XBRL Taxonomy Extension ~~Labels~~Label Linkbase ~~Document~~Document.
101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase ~~Document~~

*	~~Filed herewith.~~Document.
*104	~~Furnished.~~	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

Dated: ~~May 21, 2021~~November 14, 2022	CLARIM ACQUISITION CORP.

	By:	/s/ James F. McCann
		James F. McCann
		Chief Executive Officer and Chairman of the Board
		(Principal Executive Officer)

Dated: ~~May 21, 2021~~November 14, 2022	By:	/s/ Jaymin Patel
		Jaymin Patel
		Chief Financial Officer, President and Director
		(Principal Accounting and Financial ~~and Accounting~~ Officer)